ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
2,3,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
3,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
4,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
4,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
5,1,Cardiac septal hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
6,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
7,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
8,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
8,2,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
8,3,Renal artery thrombosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
9,1,Onycholysis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
10,1,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
11,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
11,2,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
11,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
11,4,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
12,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
13,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,2,Headache,Headaches NEC,Headaches,Nerv,N
13,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
14,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
14,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
14,3,Headache,Headaches NEC,Headaches,Nerv,N
14,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
16,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
17,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
17,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
18,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
18,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
19,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
19,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
19,3,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
20,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
21,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
22,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
23,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
24,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
25,1,Migraine,Migraine headaches,Headaches,Nerv,N
25,2,Tunnel vision,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
25,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
25,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
26,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
27,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
28,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
29,1,Hypertrophic cardiomyopathy,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
29,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
30,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
31,1,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
31,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
32,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,2,Headache,Headaches NEC,Headaches,Nerv,N
32,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
33,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
33,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
33,3,Headache,Headaches NEC,Headaches,Nerv,N
34,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
34,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
35,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
36,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
37,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
38,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
38,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
39,1,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
40,1,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
41,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
42,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
43,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
44,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
45,1,Gingival hypoplasia,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
46,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
46,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
47,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
48,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
49,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
50,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
51,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
51,2,Headache,Headaches NEC,Headaches,Nerv,N
51,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
52,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
53,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
54,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
55,1,Vitiligo,Hypopigmentation disorders,Pigmentation disorders,Skin,N
56,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
56,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
57,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
57,2,Splinter haemorrhages,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
58,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
60,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
61,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
62,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
62,2,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
62,3,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
63,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
64,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
64,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
65,1,Vagotomy,Autonomic nerve therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
66,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,Y
67,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
67,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
68,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
69,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
70,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
71,1,Psoas abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
71,2,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
72,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
72,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
73,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
74,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
75,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
75,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
76,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
77,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
78,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
78,2,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
79,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
80,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
81,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
81,2,Vagotomy,Autonomic nerve therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
82,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
83,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
83,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
84,1,Focal dyscognitive seizures,Partial complex seizures,Seizures (incl subtypes),Nerv,N
84,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
85,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
86,1,Proctalgia,Anal and rectal pains,Anal and rectal conditions NEC,Gastr,N
87,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
88,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
89,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
90,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
91,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
92,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
93,1,Glycosuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
94,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
95,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
96,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
96,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
97,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
97,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
97,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
98,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
99,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
100,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
101,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
102,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
102,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
103,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
104,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
105,1,Headache,Headaches NEC,Headaches,Nerv,N
106,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
107,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
108,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
109,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
109,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
110,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
111,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
112,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
113,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
115,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
115,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
115,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
116,1,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
117,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
117,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
117,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
117,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
117,5,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
117,6,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
117,7,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
117,8,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
117,9,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
117,10,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
118,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
119,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
120,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
120,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
121,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
122,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
123,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
123,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
124,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
125,1,Streptococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,Y
126,1,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
126,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
127,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
128,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
129,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
130,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
130,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
131,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
131,2,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,1,Acarodermatitis,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
132,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
132,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
133,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
134,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
135,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,2,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
136,1,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
136,2,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
137,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
137,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
138,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
138,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
138,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
139,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
139,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
140,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
140,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
140,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
141,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
142,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
143,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
144,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
145,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
145,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
146,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
147,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
147,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
147,3,Fat embolism,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
147,4,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
147,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
147,6,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
147,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
148,1,Pulmonary tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
149,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
150,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
150,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
151,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
152,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
152,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
152,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
152,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
152,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
153,1,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
153,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
153,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
154,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
155,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
156,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
156,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
157,1,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
158,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
158,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
158,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
158,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
158,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
159,1,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
160,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
161,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
162,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
163,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
164,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
165,1,Abnormal sensation in eye,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
165,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
165,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
165,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
165,5,Headache,Headaches NEC,Headaches,Nerv,N
166,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
167,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
168,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
168,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
168,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
169,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
170,1,Acne,Acnes,Skin appendage conditions,Skin,N
171,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
172,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
173,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
173,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
174,1,Deafness,Hearing losses,Hearing disorders,Ear,N
174,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
175,1,Cavernous sinus thrombosis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
175,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
175,3,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
175,4,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
176,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
176,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
176,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
176,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
178,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
179,1,Myelodysplastic syndrome,Myelodysplastic syndromes,Leukaemias,Neopl,N
179,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
180,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
181,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
182,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
182,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
183,1,Amaurosis,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
183,2,Maculopathy,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
184,1,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
185,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
185,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
185,3,Headache,Headaches NEC,Headaches,Nerv,N
185,4,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
186,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
186,2,Pustular psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
187,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
188,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
188,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
188,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
188,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
189,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
189,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
190,1,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
190,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
191,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
192,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
192,2,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
193,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
193,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
193,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
194,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
195,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
196,1,Glucose tolerance impaired,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
197,1,Hypertrophic cardiomyopathy,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
198,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
199,1,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
200,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
201,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
201,2,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
201,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
202,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
203,1,Pancreatitis haemorrhagic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,Y
204,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
204,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
204,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
205,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
206,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
206,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
207,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
207,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
207,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
207,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
208,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
208,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
208,3,Hepatopulmonary syndrome,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
208,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
208,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
208,6,Portal hypertension,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
208,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
208,8,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
208,9,Right ventricular failure,Right ventricular failures,Heart failures,Card,Y
209,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
209,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
210,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
210,2,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
211,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
212,1,Acne,Acnes,Skin appendage conditions,Skin,N
213,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
214,1,Fistula,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
214,2,Renal pelvis fistula,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
215,1,Follicular lymphoma,Follicular lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
216,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
217,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
217,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
218,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
219,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
220,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
220,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
220,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
220,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
222,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
222,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
223,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
223,2,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
224,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
224,2,Obstruction gastric,Gastric and pyloric stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
224,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
224,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
225,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
225,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
226,1,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
227,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
228,1,Aortic aneurysm rupture,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,Y
228,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
229,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
229,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
230,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
230,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
231,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
232,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
232,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
233,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
233,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
233,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
234,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
234,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
234,3,Hepatopulmonary syndrome,Vascular pulmonary disorders NEC,Pulmonary vascular disorders,Resp,N
234,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
234,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
234,6,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
234,7,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
234,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
234,9,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
234,10,Right ventricular failure,Right ventricular failures,Heart failures,Card,Y
235,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
235,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
235,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
235,4,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
235,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
236,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
236,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
237,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
238,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
239,1,Perioral dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
240,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
240,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
240,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
241,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
241,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
241,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
242,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
242,2,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
243,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
244,1,Retinal vein thrombosis,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
245,1,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
246,1,Tinea capitis,Tinea infections,Fungal infectious disorders,Infec,N
247,1,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
247,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
248,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
249,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
250,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
250,2,Disseminated cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
250,3,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
250,4,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
250,5,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
251,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
251,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
252,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
253,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
253,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
253,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
254,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
254,2,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
255,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
255,2,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
256,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
257,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
257,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
258,1,Enterocolitis haemorrhagic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
258,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
258,3,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
259,1,Hypotrichosis,Alopecias,Skin appendage conditions,Skin,N
260,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
261,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
262,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
263,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
264,1,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
265,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
265,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
266,1,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
266,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
266,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
266,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
267,1,Seminoma,Testicular neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
268,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
268,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
268,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
269,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
269,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
269,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
270,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
270,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
271,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
271,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
272,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
272,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
272,3,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
272,4,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
272,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
273,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
274,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
275,1,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
275,2,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
276,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
277,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
277,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
278,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
279,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
280,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
281,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
281,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
282,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
282,2,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
283,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
283,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
284,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
284,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
285,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
285,2,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
286,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
286,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
286,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
286,4,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
286,5,Graft complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
286,6,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
286,7,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
286,8,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
286,9,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
286,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
286,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
286,12,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
286,13,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
286,14,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
286,15,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
286,16,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
287,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
288,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
289,1,Radioisotope scan abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
290,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
290,2,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
290,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
290,4,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
291,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
291,2,Schistosomiasis,Trematode infections,Helminthic disorders,Infec,N
292,1,Hepatitis C virus test,Virus identification and serology,Microbiology and serology investigations,Inv,N
292,2,Schistosomiasis liver,Trematode infections,Helminthic disorders,Infec,N
293,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
293,2,Serum ferritin decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
294,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
295,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
295,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
295,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
295,4,Hepatic neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
295,5,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
295,6,Small intestinal resection,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
295,7,Small intestine carcinoma,Small intestinal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
296,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
296,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
296,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
297,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
297,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
297,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
297,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
298,1,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
299,1,Endocarditis enterococcal,Enterococcal infections,Bacterial infectious disorders,Infec,N
300,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
301,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
301,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
302,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
302,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
303,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
304,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
304,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
305,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
306,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
307,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
308,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
308,2,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
308,3,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
309,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
309,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
310,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
310,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
310,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
311,1,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
312,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
313,1,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
313,2,Ligament disorder,Ligament disorders,"Tendon, ligament and cartilage disorders",Musc,N
313,3,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
313,4,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
313,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
313,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
313,7,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
313,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
313,9,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
314,1,Corneal infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
315,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
315,2,Neurocysticercosis,Cestode infections,Helminthic disorders,Infec,N
315,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
316,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
316,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
316,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
316,4,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
316,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
317,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
317,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
318,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
318,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
318,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
318,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
318,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
318,6,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
318,7,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
319,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
320,1,Anogenital warts,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
320,2,Application site discomfort,Application site reactions,Administration site reactions,Genrl,N
321,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
322,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
322,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
322,3,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
322,4,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
322,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
322,6,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
322,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
322,8,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
322,9,Soft tissue infection,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
323,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
324,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
324,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
324,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
324,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
324,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
324,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
324,7,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
324,8,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
325,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
326,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
327,1,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
328,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
328,2,Gallbladder enlargement,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
328,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
329,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
330,1,T-cell lymphoma,Anaplastic large cell lymphomas T- and null-cell types,Lymphomas non-Hodgkin's T-cell,Neopl,N
331,1,Pancreatitis chronic,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
332,1,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
333,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
334,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
335,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
336,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
337,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
338,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
338,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
339,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
340,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
340,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
341,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
342,1,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
343,1,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
344,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
344,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
344,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
344,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
344,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
344,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
344,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
345,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
345,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
346,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
346,2,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
346,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
346,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
347,1,Bronchial carcinoma,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
348,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
349,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
349,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
350,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
351,1,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
352,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
352,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
352,3,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
352,4,Hepatic neoplasm,Hepatobiliary neoplasms malignancy unspecified,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
352,5,Intussusception,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
352,6,Small intestine carcinoma,Small intestinal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
353,1,Skin degenerative disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
354,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
355,1,Metastases to liver,Metastases to specified sites,Metastases,Neopl,Y
356,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
357,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
358,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
359,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
360,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
360,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
360,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
360,4,Myoclonic epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
361,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
362,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
363,1,Gastrointestinal cancer metastatic,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
364,1,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,Y
365,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
366,1,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
367,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
367,2,Herpes zoster disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
368,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
368,2,Herpes zoster disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
369,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
369,2,Herpes zoster disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
369,3,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,Y
369,4,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
370,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
371,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
371,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
371,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
371,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
371,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
371,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
372,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
373,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
374,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
375,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
376,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
377,1,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
377,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
378,1,Peripheral motor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
378,2,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
379,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
379,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
381,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
381,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
381,3,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
382,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
382,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
382,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
382,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
382,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
382,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
383,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
383,2,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
383,3,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
383,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
383,5,Varicella virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
383,6,Varicella zoster pneumonia,Herpes viral infections,Viral infectious disorders,Infec,N
384,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
384,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
385,1,Malignant hypertension,Accelerated and malignant hypertension,Vascular hypertensive disorders,Vasc,N
385,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
385,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
386,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
387,1,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
388,1,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
389,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
390,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
390,2,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
390,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
390,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
391,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
392,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
393,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
393,2,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
393,3,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
393,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
393,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
393,6,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
393,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
394,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
394,2,Headache,Headaches NEC,Headaches,Nerv,N
395,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
395,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
395,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
396,1,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
397,1,Brain scan abnormal,Central nervous system imaging procedures,"Neurological, special senses and psychiatric investigations",Inv,N
398,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
399,1,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
400,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
401,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
402,1,Deafness,Hearing losses,Hearing disorders,Ear,N
403,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
403,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
403,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
403,4,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
403,5,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
404,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
405,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
406,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
407,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
407,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
407,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
407,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
408,1,Deafness,Hearing losses,Hearing disorders,Ear,N
409,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
409,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
409,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
409,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
410,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
411,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
412,1,Application site irritation,Application site reactions,Administration site reactions,Genrl,N
412,2,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
412,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
412,4,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
412,5,Keratosis follicular,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
413,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
414,1,Pneumococcal sepsis,Streptococcal infections,Bacterial infectious disorders,Infec,N
414,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
415,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
415,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
415,3,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
416,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
416,2,Headache,Headaches NEC,Headaches,Nerv,N
416,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
416,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
417,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
417,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
417,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
418,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
418,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
419,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
419,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
419,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
419,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
419,5,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
420,1,Polycythaemia,Polycythaemia (excl rubra vera),Red blood cell disorders,Blood,N
421,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
422,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
423,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
423,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
423,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
423,4,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
423,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
423,6,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
423,7,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
423,8,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
423,9,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
423,10,Tracheal obstruction,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
424,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
424,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
424,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
424,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
425,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
425,2,Oxalosis,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
426,1,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
427,1,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
428,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
429,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
429,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
430,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
430,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
430,3,Non-cardiogenic pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
431,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
431,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
432,1,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
432,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
433,1,Hirsutism,Hypertrichoses,Skin appendage conditions,Skin,N
434,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
434,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
435,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
435,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
436,1,Deafness,Hearing losses,Hearing disorders,Ear,N
436,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
436,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
436,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
436,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
436,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
436,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
437,1,Bladder transitional cell carcinoma,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
437,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
437,3,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
437,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
438,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
438,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
438,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
438,4,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
439,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
439,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
439,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
439,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
440,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
440,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
441,1,Drug level changed,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
441,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
442,1,Drug level changed,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
442,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
443,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
443,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
444,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
444,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
445,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
445,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
445,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
445,4,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
445,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
445,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
445,7,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
445,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
445,9,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
445,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
445,11,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
445,12,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
445,13,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
445,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
445,15,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
445,16,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
445,17,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
445,18,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
445,19,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
446,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
447,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
448,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
449,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
450,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
451,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
451,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
451,3,Infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
451,4,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
451,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
451,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
452,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
452,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
453,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
453,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
453,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
454,1,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
455,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
456,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
456,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
456,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
457,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
458,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
459,1,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
459,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
460,1,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
460,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
460,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
461,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
461,2,Bursitis infective,Bone and joint infections,Infections - pathogen unspecified,Infec,N
461,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
461,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
461,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
461,6,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
461,7,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
461,8,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
462,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
462,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
463,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
463,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
464,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
465,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
465,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
465,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
466,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
467,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
467,2,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
468,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
469,1,Burkholderia cepacia complex infection,Burkholderia infections,Bacterial infectious disorders,Infec,N
470,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
471,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
471,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
472,1,Disseminated cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
473,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
474,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
474,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
474,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
475,1,Orchitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
476,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
476,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
476,3,Myopathy,Myopathies,Muscle disorders,Musc,N
477,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
477,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
477,3,Cystitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
477,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
477,5,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
477,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
477,7,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
477,8,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
477,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
477,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
477,11,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
478,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
478,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
479,1,Breast discharge,Breast signs and symptoms,Breast disorders,Repro,N
480,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
481,1,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
481,2,Catheter removal,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
481,3,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
481,4,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
481,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
481,6,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
481,7,Red blood cell schistocytes present,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
481,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
481,9,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
481,10,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
482,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
482,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
483,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
484,1,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
484,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
484,3,Encapsulating peritoneal sclerosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
484,4,Hepatic haematoma,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
484,5,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
484,6,Small intestinal obstruction,Duodenal and small intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
485,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
486,1,Hypercholesterolaemia,Elevated cholesterol,Lipid metabolism disorders,Metab,N
487,1,Cholecystitis infective,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
487,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
487,3,Gallbladder rupture,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
487,4,Haemobilia,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
488,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
489,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
490,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
491,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
492,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
492,2,Hepatoblastoma recurrent,Hepatoblastomas,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
492,3,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
493,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
493,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
493,3,Burkitt's lymphoma stage III,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
493,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
493,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
493,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
494,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
495,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
495,2,Hepatoblastoma recurrent,Hepatoblastomas,Hepatobiliary neoplasms malignant and unspecified,Neopl,Y
495,3,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
496,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
496,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
497,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
498,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
498,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
498,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
498,4,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
498,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
498,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
498,7,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
498,8,Tic,Tic disorders,Changes in physical activity,Psych,N
499,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
500,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
500,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
501,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
501,2,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
501,3,Device related bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
501,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
501,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
501,6,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
501,7,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
501,8,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
501,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
501,10,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
501,11,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
501,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
501,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
501,14,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
501,15,Tic,Tic disorders,Changes in physical activity,Psych,N
502,1,Pseudarthrosis,Fracture complications,Fractures,Musc,N
503,1,Burkitt's leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
503,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
504,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
504,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
504,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
504,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
504,5,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
504,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
504,7,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
504,8,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
504,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
504,10,Peritoneal disorder,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
504,11,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
504,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
504,13,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
505,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
505,2,Myoclonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
505,3,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
506,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
507,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
507,2,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
507,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
507,4,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
508,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
508,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
509,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
509,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
509,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
509,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
509,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
509,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
510,1,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
511,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
511,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
511,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
512,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
512,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
512,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
512,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
513,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
513,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
513,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
513,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
514,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
514,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
515,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
516,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
517,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
517,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
517,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
517,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
518,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
518,2,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
519,1,Acne,Acnes,Skin appendage conditions,Skin,N
519,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
520,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
521,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
521,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
522,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
522,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
522,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
523,1,Breast atrophy,Breast disorders NEC,Breast disorders,Repro,N
524,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
524,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
524,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
524,4,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
524,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
524,6,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
524,7,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
524,8,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
524,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
524,10,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
524,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
524,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
525,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
526,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
527,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
527,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
528,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
529,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
530,1,Lung infiltration,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
531,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
531,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
531,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
532,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
532,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
533,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
533,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
534,1,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
534,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
535,1,Lip squamous cell carcinoma,Lip and oral cavity neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
535,2,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
536,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
537,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
537,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
537,3,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
537,4,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
538,1,Deafness unilateral,Hearing losses,Hearing disorders,Ear,N
539,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
540,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
540,2,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
540,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
541,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
542,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
542,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
542,3,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
542,4,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
542,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
543,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
543,2,Change of bowel habit,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
543,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
543,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
543,5,Graft complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
543,6,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
543,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
544,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
544,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
545,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
546,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
546,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
547,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
547,2,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
548,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
549,1,Bone marrow oedema,Haematological disorders,Haematological disorders NEC,Blood,N
550,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
550,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
550,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
551,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
551,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
551,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
552,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
552,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
552,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
553,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
554,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
555,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
556,1,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
556,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
556,3,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
556,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
557,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
557,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
557,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
557,4,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
557,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
557,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
558,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
558,2,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
558,3,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
558,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
558,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
558,6,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
558,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
558,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
559,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
559,2,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
559,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
559,4,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
559,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
559,6,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
559,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
560,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
561,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
562,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
563,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
563,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
564,1,Azotaemia,Renal failure complications,Renal disorders (excl nephropathies),Renal,N
564,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
564,3,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
564,4,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
564,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
565,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
566,1,Atypical mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,Y
566,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
566,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
567,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
567,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
567,3,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
567,4,Fungal sepsis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
567,5,Graft versus host disease in liver,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
567,6,Haemoglobin abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
567,7,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
567,8,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
568,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
569,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
570,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
571,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
571,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
571,3,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
572,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
573,1,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
574,1,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
574,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
575,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
576,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
577,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
577,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
578,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
579,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
579,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
579,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
579,4,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
579,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
579,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
579,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
580,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
581,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
581,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
581,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
582,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
582,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
583,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
583,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
583,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
584,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
585,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
586,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
586,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
586,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
587,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
588,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
589,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
589,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
589,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
590,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
591,1,Pyogenic granuloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
592,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
592,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
592,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
593,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
593,2,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
594,1,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
595,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
596,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
597,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
598,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
599,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
599,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
599,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
599,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
599,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
599,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
600,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
601,1,Castleman's disease,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
601,2,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
601,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,Y
602,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
602,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
602,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
603,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
603,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
603,3,Glomerulonephritis membranoproliferative,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
603,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
603,5,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
603,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
603,7,Post streptococcal glomerulonephritis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
603,8,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
603,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
603,10,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
603,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
603,12,Streptococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
603,13,Upper respiratory tract infection,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
603,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
604,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
604,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
604,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
604,4,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
605,1,Onychomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
606,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
606,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
606,3,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
607,1,Cushingoid,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
607,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
607,3,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
607,4,Tubulointerstitial nephritis and uveitis syndrome,Nephritis NEC,Nephropathies,Renal,N
608,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
608,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
609,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
609,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
610,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
610,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
611,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
612,1,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
612,2,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
612,3,Ocular vasculitis,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
612,4,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
612,5,Venous occlusion,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
612,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
612,7,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
613,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
614,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
614,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
614,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
614,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
614,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
614,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
614,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
615,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
615,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
616,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,Y
616,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
617,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
617,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
618,1,Coombs positive haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,Y
618,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
619,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
619,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
620,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
620,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
620,3,Herpes simplex hepatitis,Herpes viral infections,Viral infectious disorders,Infec,N
620,4,Herpes zoster disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
621,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
621,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
621,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
621,4,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
621,5,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
621,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
621,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
622,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
622,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
622,3,Increased viscosity of bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
622,4,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
622,5,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
622,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
622,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
623,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
623,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
623,3,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
623,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
623,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
624,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
624,2,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
624,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
624,4,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
624,5,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
625,1,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
626,1,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
627,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
627,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
627,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
627,4,Increased viscosity of bronchial secretion,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
627,5,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
627,6,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
627,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
627,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
628,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
628,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
628,3,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
628,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
628,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
629,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
629,2,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
629,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
629,4,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
629,5,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
630,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
630,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
630,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
630,4,Electroencephalogram abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
630,5,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
630,6,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
630,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
631,1,Hypertrophic cardiomyopathy,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
632,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
632,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,Y
633,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
633,2,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
633,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
633,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
634,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
634,2,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
635,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
636,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
636,2,Metastases to lung,Metastases to specified sites,Metastases,Neopl,Y
637,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
637,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
637,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
637,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
637,5,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
637,6,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
637,7,Upper motor neurone lesion,Motor neurone diseases,Neuromuscular disorders,Nerv,N
638,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
639,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
639,2,Arteriovenous fistula,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
639,3,Bone marrow oedema,Haematological disorders,Haematological disorders NEC,Blood,N
639,4,Bone metabolism disorder,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
639,5,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
640,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
640,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
640,3,Hyperplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
640,4,Mycetoma mycotic,Fungal infections NEC,Fungal infectious disorders,Infec,N
640,5,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
640,6,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
640,7,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
640,8,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
640,9,Subcutaneous abscess,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
641,1,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
641,2,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
641,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
641,4,Fungal peritonitis,Fungal infections NEC,Fungal infectious disorders,Infec,N
641,5,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
641,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
641,7,Peritoneal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
641,8,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
641,9,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
642,1,Multiple cardiac defects,Multiple cardiac abnormalities congenital,Cardiac and vascular disorders congenital,Cong,Y
643,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
644,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
644,2,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
645,1,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
645,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
645,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
645,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
645,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
646,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
646,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
646,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
647,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
647,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
647,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
647,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
647,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
647,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
647,7,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
648,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
649,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
649,2,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
650,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
651,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
651,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
651,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
652,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
652,2,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
652,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
652,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
652,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
652,6,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
652,7,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
652,8,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
652,9,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
652,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
652,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
653,1,Renal tubular disorder,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
654,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
655,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
655,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
655,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
655,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
655,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
656,1,Autoimmune pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
656,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
656,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
657,1,Glomerulonephritis acute,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
658,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
659,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
659,2,Peritonitis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
660,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
661,1,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
661,2,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
662,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
662,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
663,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
664,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
664,2,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
665,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
666,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
666,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
666,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
667,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
667,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
667,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
667,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
667,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
667,6,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
668,1,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
668,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
669,1,Headache,Headaches NEC,Headaches,Nerv,N
669,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
670,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
671,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
672,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
673,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
673,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
674,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
674,2,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
674,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
674,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
674,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
674,6,Hepatic cyst,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
674,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
674,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
674,9,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
674,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
675,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
675,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
675,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
676,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
676,2,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
677,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
677,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
678,1,Deafness,Hearing losses,Hearing disorders,Ear,N
678,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
679,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
680,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
680,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
680,3,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
680,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
680,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
680,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
681,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
681,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
681,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
681,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
681,5,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
681,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
681,7,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
681,8,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
682,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
683,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
683,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
683,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
683,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
683,5,Peripheral sensory neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
683,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
683,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
684,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
684,2,Follicular thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
684,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
684,4,Obesity,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
685,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
686,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
687,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
687,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
687,3,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
687,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
687,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
687,6,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
688,1,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
689,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
689,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
690,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
691,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
692,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
693,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
693,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
693,3,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
694,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
694,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
695,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
696,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
697,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
697,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
697,3,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
698,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
699,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
699,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
699,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
699,4,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
699,5,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
700,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
701,1,Neuropathic arthropathy,Osteoarthropathies,Joint disorders,Musc,N
702,1,Neuropathic arthropathy,Osteoarthropathies,Joint disorders,Musc,N
703,1,Neuropathic arthropathy,Osteoarthropathies,Joint disorders,Musc,N
704,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
705,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
705,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
706,1,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
707,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
707,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
707,3,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
708,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
708,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
708,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
708,4,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
708,5,Chronic graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
708,6,Chronic graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
708,7,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
708,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
708,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
708,10,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
708,11,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
708,12,Joint contracture,Joint related disorders NEC,Joint disorders,Musc,N
708,13,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
708,14,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
708,15,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
708,16,Palmar-plantar erythrodysaesthesia syndrome,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
708,17,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
708,18,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
708,19,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
708,20,Skin hypopigmentation,Hypopigmentation disorders,Pigmentation disorders,Skin,N
708,21,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
709,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
709,2,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
710,1,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
711,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
711,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
712,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
713,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
713,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
713,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
714,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
714,2,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
714,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
714,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
714,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
714,6,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
715,1,Gastrointestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
715,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
716,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
716,2,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
717,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
717,2,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
717,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
718,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
718,2,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
718,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
718,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
719,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
719,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
719,3,Opsoclonus myoclonus,Encephalopathies NEC,Encephalopathies,Nerv,N
720,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
720,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
720,3,Headache,Headaches NEC,Headaches,Nerv,N
720,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
720,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
720,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
721,1,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
722,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
723,1,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
723,2,Prosthetic valve endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
724,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
724,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
725,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
725,2,Catheter site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
725,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
725,4,Intra-abdominal fluid collection,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
725,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
725,6,Pasteurella test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
725,7,Prosthetic valve endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
725,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
725,9,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
725,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
726,1,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
726,2,Prosthetic valve endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
727,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
727,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
727,3,Catheter site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
727,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
727,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
727,6,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
727,7,Prosthetic valve endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
727,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
727,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
727,10,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
727,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
728,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
728,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
729,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
729,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
729,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
729,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
730,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
730,2,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
730,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,Y
730,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
731,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
731,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
731,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
731,4,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
731,5,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
731,6,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
731,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
731,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
732,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
732,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
733,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
733,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
734,1,Endocarditis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
734,2,Pasteurella infection,Pasteurella infections,Bacterial infectious disorders,Infec,N
735,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
736,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
737,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
738,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
738,2,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
739,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
739,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
739,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
739,4,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
740,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
740,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
741,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
742,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
742,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
742,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
742,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
742,5,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
742,6,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
742,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
742,8,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
742,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
742,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
743,1,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
744,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
745,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
745,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
746,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
746,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
746,3,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
746,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
746,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
747,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
747,2,Sebaceous carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
747,3,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
748,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
748,2,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
748,3,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
748,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
748,5,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
749,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
750,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
750,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
750,3,Molluscum contagiosum,Molluscum contagiosum viral infections,Viral infectious disorders,Infec,N
750,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
751,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
751,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
752,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
752,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
752,3,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
752,4,Colonoscopy abnormal,Gastrointestinal and abdominal imaging procedures,Gastrointestinal investigations,Inv,N
752,5,Gastrointestinal hypomotility,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
752,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
752,7,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
752,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
752,9,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
753,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
754,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
755,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
755,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
755,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
755,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
755,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
755,6,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
755,7,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
756,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
756,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
757,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
758,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
759,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
759,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
760,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
761,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
761,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
762,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
762,2,Dermatitis acneiform,Acnes,Skin appendage conditions,Skin,N
762,3,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
762,4,Herpes simplex hepatitis,Herpes viral infections,Viral infectious disorders,Infec,N
762,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
763,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
763,2,Pancreatic disorder,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
763,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
763,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
764,1,Cerebral small vessel ischaemic disease,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
764,2,Lacunar infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
765,1,Adenoidal hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
765,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
765,3,Lymphoid tissue hyperplasia,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
765,4,Obstructive sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
765,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
765,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
765,7,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
765,8,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
766,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
767,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
767,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
768,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
768,2,Foetal monitoring abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
769,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
769,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
769,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
769,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
770,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
770,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
770,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
770,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
771,1,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
771,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
771,3,Headache,Headaches NEC,Headaches,Nerv,N
771,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
771,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
771,6,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
771,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
771,8,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
771,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
771,10,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
771,11,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
772,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
773,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
773,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
773,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
773,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
774,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
774,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
774,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
774,4,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
774,5,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
774,6,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
774,7,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
774,8,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
774,9,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
774,10,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
774,11,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
774,12,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
774,13,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
774,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
775,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
776,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
777,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
777,2,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
777,3,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
778,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
779,1,Breast cancer male,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
780,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
780,2,Headache,Headaches NEC,Headaches,Nerv,N
780,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
780,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
781,1,Invasive ductal breast carcinoma,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
781,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
782,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
782,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
783,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
784,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
785,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
785,2,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
785,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
785,4,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
786,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
786,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
787,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
787,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
788,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
788,2,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
788,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
789,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
789,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
790,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
790,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
791,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
791,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
791,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
791,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
792,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
792,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
793,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
793,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
793,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
793,4,Granuloma,Inflammations,General system disorders NEC,Genrl,N
793,5,Histology abnormal,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
793,6,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
793,7,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
793,8,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
793,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
793,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
794,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
794,2,Anastomotic ulcer,Gastrointestinal and hepatobiliary procedural complications,Procedural related injuries and complications NEC,Inj&P,N
794,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
794,4,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
794,5,Enteritis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
794,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
794,7,Norovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
794,8,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
794,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
794,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
794,11,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
794,12,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
794,13,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
795,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
795,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
796,1,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
797,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
797,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
797,3,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
797,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
798,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
798,2,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
799,1,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
799,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
799,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
799,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
800,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
800,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
800,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
800,4,Polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
800,5,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
800,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
801,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
801,2,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
802,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
802,2,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
802,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
802,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
802,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
802,6,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
803,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
803,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
803,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
803,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
804,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
804,2,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
804,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
804,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
805,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
805,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
806,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
806,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
806,3,Endocrine ophthalmopathy,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
806,4,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
806,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
806,6,Graves' disease,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
806,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
806,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
807,1,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
807,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
808,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
808,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
808,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
808,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
809,1,Coronary artery dissection,Coronary artery disorders NEC,Coronary artery disorders,Card,N
810,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
810,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
810,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
811,1,Areflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
811,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
811,3,CSF protein increased,Cerebrospinal fluid tests (excl microbiology),"Neurological, special senses and psychiatric investigations",Inv,N
811,4,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
811,5,Demyelination,Demyelinating disorders NEC,Demyelinating disorders,Nerv,N
811,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
811,7,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
811,8,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
811,9,Joint range of motion decreased,Joint related signs and symptoms,Joint disorders,Musc,N
811,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
811,11,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
812,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
813,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
813,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
813,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
813,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
813,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
813,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
814,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
815,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
815,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
816,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
816,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
817,1,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
817,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
817,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
818,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
818,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
818,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
818,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
818,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
819,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
819,2,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
819,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
820,1,Arteritis infective,Vascular infections,Infections - pathogen unspecified,Infec,N
821,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
821,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
821,3,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
821,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
821,5,Death,Death and sudden death,Fatal outcomes,Genrl,Y
821,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
821,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
821,8,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
821,9,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
821,10,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
821,11,Mediastinitis,Infections NEC,Infections - pathogen unspecified,Infec,N
821,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
821,13,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
821,14,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
821,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
822,1,Arteritis infective,Vascular infections,Infections - pathogen unspecified,Infec,N
822,2,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
823,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
824,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
824,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
825,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
825,2,Tuberculosis liver,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
826,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
826,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
827,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
828,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
829,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
830,1,Candida sepsis,Candida infections,Fungal infectious disorders,Infec,N
830,2,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
830,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
830,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
830,5,Klebsiella sepsis,Klebsiella infections,Bacterial infectious disorders,Infec,Y
830,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
830,7,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
831,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
832,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
833,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
833,2,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
833,3,Liver abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
833,4,Parotitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
833,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
834,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
835,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
835,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
835,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
836,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
836,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
837,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
837,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
837,3,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
837,4,Red cell fragmentation syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
837,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
837,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
837,7,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
838,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
839,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
840,1,Acne,Acnes,Skin appendage conditions,Skin,N
841,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
842,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
843,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
844,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
844,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
844,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
844,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
844,5,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
844,6,Otorrhoea,Ear disorders NEC,Aural disorders NEC,Ear,N
844,7,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
844,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
844,9,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
845,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
845,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
845,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
846,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
846,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
846,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
847,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
848,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
848,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
848,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
849,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
850,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
851,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
851,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
852,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
853,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
854,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
854,2,Gastroenteritis salmonella,Salmonella infections,Bacterial infectious disorders,Infec,N
854,3,Infective aortitis,Vascular infections,Infections - pathogen unspecified,Infec,N
854,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
854,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
854,6,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
854,7,Salmonella bacteraemia,Salmonella infections,Bacterial infectious disorders,Infec,N
855,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
855,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
855,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
855,4,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
856,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
857,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
857,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
857,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
858,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
858,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
859,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
859,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
860,1,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
861,1,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
861,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
862,1,Food allergy,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
862,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
863,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
863,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
863,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
863,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
864,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
865,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
865,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
866,1,Benign ovarian tumour,Ovarian neoplasms benign,Reproductive neoplasms female benign,Neopl,N
867,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
867,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
868,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
868,2,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
869,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
870,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
871,1,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
872,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
872,2,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
873,1,Fungating wound,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
873,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
873,3,Mycetoma mycotic,Fungal infections NEC,Fungal infectious disorders,Infec,N
874,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
874,2,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
875,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
876,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
877,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
877,2,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
878,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
879,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
879,2,Blindness cortical,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
879,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
879,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
879,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
879,6,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,Y
879,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
879,8,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
880,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
881,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
882,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
882,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
883,1,Transient acantholytic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
884,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
885,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
886,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
887,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
887,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
888,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
889,1,Hyperglycaemic hyperosmolar nonketotic syndrome,Diabetic complications neurological,Diabetic complications,Metab,N
890,1,Application site swelling,Application site reactions,Administration site reactions,Genrl,N
890,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
890,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
890,4,Transient acantholytic dermatosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
891,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
891,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
892,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
892,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
893,1,Anisocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
893,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
893,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
893,4,Poikilocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
893,5,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
893,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
894,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
894,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
894,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
894,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
894,5,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
894,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
895,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
896,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
897,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
897,2,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
897,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
898,1,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
898,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
898,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
899,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
900,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
901,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
902,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
903,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
904,1,Lower respiratory tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
905,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
905,2,Second primary malignancy,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
906,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
907,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
907,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
907,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
907,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
908,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
908,2,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
909,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
910,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
910,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
911,1,Acne,Acnes,Skin appendage conditions,Skin,N
911,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
911,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
911,4,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
911,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
911,6,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
911,7,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
912,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
912,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
912,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
912,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
912,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
913,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
913,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
913,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
914,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,Y
914,2,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
915,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,Y
916,1,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
917,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
918,1,Rhesus antibodies positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
919,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
920,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
921,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
922,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
922,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
922,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
923,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
923,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
923,3,Intestine transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
923,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
923,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
923,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
924,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
924,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
924,3,Intestine transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
924,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
924,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
924,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
925,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
925,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
926,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
926,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
926,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
926,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
926,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
926,6,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
926,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
926,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
927,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
928,1,Headache,Headaches NEC,Headaches,Nerv,N
928,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
929,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
930,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
931,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
931,2,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
931,3,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
931,4,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
931,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
932,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
933,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
934,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
935,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
936,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
937,1,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
938,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
939,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
939,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
939,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
939,4,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
939,5,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
939,6,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
939,7,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
939,8,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
939,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
939,10,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
940,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
940,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
941,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
941,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
942,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
943,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
943,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
944,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
944,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
945,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
946,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
947,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
947,2,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
948,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
949,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
949,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
950,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
951,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
951,2,Drug level changed,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
951,3,Headache,Headaches NEC,Headaches,Nerv,N
951,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
951,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
952,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
952,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
952,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
952,4,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
952,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
952,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
953,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
954,1,Abscess limb,Infections NEC,Infections - pathogen unspecified,Infec,N
954,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
955,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
955,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
956,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
956,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
956,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
957,1,Empyema,Infections NEC,Infections - pathogen unspecified,Infec,N
957,2,Mediastinal abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
957,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
957,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
958,1,Cystoid macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
958,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
958,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
958,4,Macular scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
959,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
960,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
961,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
962,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
963,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
963,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
963,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
964,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
965,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
966,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
966,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
966,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
967,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
968,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
969,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
970,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
970,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
971,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
972,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
972,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
972,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
973,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
973,2,Cervical dysplasia,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
973,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
973,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
974,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
975,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
975,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
976,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
976,2,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
977,1,Breast cancer metastatic,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
977,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
978,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
978,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
979,1,Viral test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
980,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
980,2,Acanthosis,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
980,3,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
980,4,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
980,5,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
980,6,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
980,7,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
981,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
982,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
983,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
984,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
985,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
986,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
987,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
988,1,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
988,2,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
988,3,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
989,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
990,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
991,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
991,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
992,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
992,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
992,3,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
992,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
993,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
993,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
993,3,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
994,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
995,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
995,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
996,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
997,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
998,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
999,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
999,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
999,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
999,4,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
999,5,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
999,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
999,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1000,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1001,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1002,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1003,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1004,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1005,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1005,2,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1005,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1005,4,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1005,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1005,6,Strabismus,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
1005,7,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1006,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1006,2,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
1007,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1008,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1008,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1009,1,Haemorrhagic cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1010,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1011,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,Y
1011,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1011,3,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1011,4,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1012,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1012,2,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
1013,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1013,2,Pneumocystis jirovecii infection,Pneumocystis infections,Fungal infectious disorders,Infec,N
1013,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1013,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1013,5,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1014,1,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1014,2,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1015,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1016,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1017,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1018,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1019,1,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1020,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1021,1,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1022,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
1022,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1022,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1022,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1023,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1023,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1024,1,Gastrointestinal erosion,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1024,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1024,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1025,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1026,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1026,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1026,3,Eczema weeping,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1026,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1026,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1026,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1026,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1026,8,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1026,9,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1026,10,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1027,1,Leukoencephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1027,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1028,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1028,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1029,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1030,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1031,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1032,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1033,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1034,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1035,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1036,1,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1037,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1038,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1039,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1040,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1041,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1042,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1043,1,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
1043,2,Parkinsonism,Parkinson's disease and parkinsonism,Movement disorders (incl parkinsonism),Nerv,N
1044,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1045,1,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
1045,2,Iniencephaly,Musculoskeletal and connective tissue disorders of skull congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
1045,3,Neural tube defect,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
1045,4,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1045,5,Teratogenicity,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1046,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1047,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1048,1,Ileal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1048,2,Large intestine polyp,Benign neoplasms gastrointestinal (excl oral cavity),Benign neoplasms gastrointestinal,Gastr,N
1048,3,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1048,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1048,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1048,6,Smooth muscle cell neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1049,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
1050,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1051,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1052,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1053,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1054,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1055,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1056,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
1057,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1057,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1058,1,Bronchitis,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1058,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1058,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1059,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1060,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1061,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1061,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1061,3,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1061,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1062,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1063,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1064,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1065,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1065,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1066,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1067,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1068,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1069,1,Lung transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1069,2,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
1070,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1071,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1072,1,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1073,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1074,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1074,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1075,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1076,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1077,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1078,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1079,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1080,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1081,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
1082,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1082,2,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
1082,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1083,1,Transplantation complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1084,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1085,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1085,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1086,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1087,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1088,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1088,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1089,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1090,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
1090,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1091,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1091,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1091,3,Urethral stent insertion,Urethral therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1091,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1092,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1093,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1094,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1095,1,Abdominal wall disorder,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1095,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1095,3,Metastases to bone,Metastases to specified sites,Metastases,Neopl,N
1095,4,Metastases to lung,Metastases to specified sites,Metastases,Neopl,N
1095,5,Metastases to spine,Metastases to specified sites,Metastases,Neopl,N
1095,6,Perinephric abscess,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1095,7,Spinal cord compression,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
1095,8,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1095,9,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1096,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1097,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1098,1,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1098,2,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1098,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1098,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1098,5,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1098,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1098,7,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1098,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1098,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1099,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1099,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1100,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1101,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1101,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1101,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1101,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1101,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1102,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1103,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1104,1,Internal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1105,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1106,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1106,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1106,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1106,4,Metapneumovirus infection,Viral infections NEC,Viral infectious disorders,Infec,N
1106,5,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1106,6,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1107,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1107,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1107,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1107,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1107,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1107,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1108,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1109,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1110,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1111,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1111,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1111,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1112,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1112,2,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
1113,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1114,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1115,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1116,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1117,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1117,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1117,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1118,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1118,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1118,3,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1119,1,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1120,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1121,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1122,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1122,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1122,3,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1123,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
1123,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1123,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1124,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1124,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1125,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1126,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1127,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1127,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1128,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1128,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1129,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1130,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1130,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1131,1,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
1132,1,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1133,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1133,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1133,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1134,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1134,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1134,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1135,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1136,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1136,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1137,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1137,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1137,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1138,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1139,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1140,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1141,1,Spinal operation,Spine and spinal cord therapeutic procedures,"Nervous system, skull and spine therapeutic procedures",Surg,N
1142,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1143,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1143,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1143,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1144,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1145,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1146,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1146,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1147,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1148,1,Retinal vein occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1148,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1148,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1149,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1149,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1150,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1151,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1152,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1153,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1153,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1154,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1154,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1155,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1155,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1155,3,Tubulointerstitial nephritis and uveitis syndrome,Nephritis NEC,Nephropathies,Renal,N
1156,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1156,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1157,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1157,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1158,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1158,2,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1159,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1160,1,Abdominal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1160,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1160,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1161,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1162,1,Diffuse large B-cell lymphoma,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,Y
1163,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1163,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1164,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1165,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1166,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1167,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1167,2,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1168,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1168,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1169,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
1169,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1170,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1171,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1171,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1171,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
1172,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1172,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1173,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1173,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1173,3,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
1173,4,Lymphadenopathy mediastinal,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1174,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1175,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1176,1,Dementia Alzheimer's type,Alzheimer's disease (incl subtypes),Mental impairment disorders,Nerv,N
1177,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
1178,1,Removal of renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1179,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1180,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1181,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1182,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
1182,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1182,3,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1183,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1183,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1183,3,Glaucoma,Glaucomas (excl congenital),Glaucoma and ocular hypertension,Eye,N
1183,4,Optic ischaemic neuropathy,Optic nerve bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
1184,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1185,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1186,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1187,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1188,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1189,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
1190,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1191,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1191,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1192,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1192,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1193,1,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1193,2,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1194,1,Diffuse alopecia,Alopecias,Skin appendage conditions,Skin,N
1195,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1196,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1197,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1198,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1198,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1198,3,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1198,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1199,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1200,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1201,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1202,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1203,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1203,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1203,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1204,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1205,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1206,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1207,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1207,2,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1208,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1209,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1210,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1210,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1211,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1211,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1212,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1213,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1214,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1215,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1216,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1216,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1217,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1218,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1218,2,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1219,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
1220,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1220,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1220,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1220,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1221,1,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1222,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1223,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1223,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1223,3,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1223,4,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1223,5,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1224,1,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1224,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1225,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
1226,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1226,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1226,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1227,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1228,1,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
1229,1,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1230,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1231,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1231,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1231,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1231,4,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1232,1,Varicella zoster pneumonia,Herpes viral infections,Viral infectious disorders,Infec,Y
1233,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1234,1,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1235,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1236,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1236,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1237,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1237,2,Alveolitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1237,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1237,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1237,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1237,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1237,7,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1237,8,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1238,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1239,1,Throat cancer,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1240,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1241,1,Pyoderma gangrenosum,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1241,2,Splenic abscess,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
1242,1,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1243,1,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1244,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1245,1,Biopsy skin abnormal,Skin histopathology and skin investigations NEC,Skin investigations,Inv,N
1245,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1245,3,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1245,4,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1245,5,Purulent discharge,Infections NEC,Infections - pathogen unspecified,Infec,N
1245,6,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1246,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1247,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1248,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1249,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1249,2,Biopsy skin abnormal,Skin histopathology and skin investigations NEC,Skin investigations,Inv,N
1249,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1249,4,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1249,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1250,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1250,2,Cerebral atrophy,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1250,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1250,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1250,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1250,6,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1250,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1250,8,Migraine without aura,Migraine headaches,Headaches,Nerv,N
1250,9,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1250,10,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1250,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1250,12,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1250,13,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1251,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1252,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1253,1,Disseminated cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1254,1,Cutaneous T-cell lymphoma,Mycoses fungoides,Lymphomas non-Hodgkin's T-cell,Neopl,N
1254,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1255,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1255,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1256,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1256,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1256,3,Headache,Headaches NEC,Headaches,Nerv,N
1256,4,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1256,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1256,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1256,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1257,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1258,1,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1258,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1259,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1260,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1261,1,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1261,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1262,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1263,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1264,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1265,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1266,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1267,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1268,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1269,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1270,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1271,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1272,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1272,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1272,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1273,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1274,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1274,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1275,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1276,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1277,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1278,1,Blood calcium abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1279,1,Cow pox,Orthopox viral infections,Viral infectious disorders,Infec,N
1279,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1279,3,Mandibular mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1279,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1279,5,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1279,6,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1279,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1279,8,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1279,9,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1279,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1279,11,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1279,12,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1279,13,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1279,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1279,15,Tonsillar inflammation,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1279,16,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1279,17,Upper airway obstruction,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1280,1,Hepatitis C,Hepatitis virus infections,Viral infectious disorders,Infec,N
1281,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1281,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1282,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1282,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1282,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1282,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1282,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1282,6,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1282,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1283,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1283,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1284,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1285,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
1285,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1286,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1286,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1287,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1288,1,Hand fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1289,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1290,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1291,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1292,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1292,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1292,3,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1292,4,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1292,5,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1292,6,Spinal cord haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1292,7,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
1293,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1293,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1293,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1294,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1295,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1296,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1297,1,Anti-neutrophil cytoplasmic antibody positive vasculitis,Vasculitides,Immune disorders NEC,Immun,N
1297,2,Glomerulonephritis acute,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1297,3,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1298,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1299,1,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1299,2,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1300,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1301,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1301,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1302,1,Acne,Acnes,Skin appendage conditions,Skin,N
1302,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1302,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1302,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1302,5,Nail disorder,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
1302,6,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
1302,7,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1303,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1303,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1304,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1304,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1305,1,Sciatica,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
1306,1,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1307,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1308,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1309,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1310,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1311,1,Disability,Disability issues,Lifestyle issues,SocCi,N
1311,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1312,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1313,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1314,1,Clavicle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1314,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1314,3,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
1315,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1316,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1317,1,Application site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1317,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1317,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1318,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1319,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1320,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1321,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1322,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1323,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1324,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1324,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1324,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1324,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1324,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1324,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1324,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1325,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1326,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1327,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1327,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1327,3,Concomitant disease aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1327,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1327,5,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1327,6,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1327,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1328,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1329,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1329,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1330,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1331,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1332,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1333,1,Chemotherapy,Chemotherapies,Therapeutic procedures and supportive care NEC,Surg,N
1334,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1334,2,Neuropathic arthropathy,Osteoarthropathies,Joint disorders,Musc,N
1334,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1335,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1336,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1336,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1336,3,Oesophageal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1337,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1337,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1338,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1339,1,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
1339,2,Foetal monitoring abnormal,Foetal and neonatal diagnostic procedures,Foetal and neonatal investigations,Inv,N
1339,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1339,4,Neonatal respiratory distress,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
1339,5,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1339,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1340,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
1340,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1340,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1340,4,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1341,1,Atrioventricular block first degree,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
1341,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1341,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1342,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1343,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1343,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1343,3,Reticulocyte count abnormal,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1344,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1345,1,Cow pox,Orthopox viral infections,Viral infectious disorders,Infec,N
1345,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1345,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1346,1,Pharyngeal haemorrhage,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1347,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1348,1,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1349,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1350,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1351,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1352,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1353,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1353,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1353,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1353,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1354,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1354,2,Pseudopolyp,Inflammations,General system disorders NEC,Genrl,N
1354,3,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1355,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1356,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1357,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1358,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1359,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
1359,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1360,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1361,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1362,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1363,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1364,1,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1365,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1365,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1366,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1367,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1367,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1367,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1367,4,Systemic immune activation,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1368,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1369,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1370,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1370,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1370,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1371,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1372,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1372,2,Exposure via body fluid,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
1372,3,Exposure via partner,Pathways and sources of exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
1373,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1374,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1375,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1375,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1375,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1375,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1376,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
1376,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1376,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1376,4,Otitis externa,Ear infections,Infections - pathogen unspecified,Infec,N
1376,5,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1376,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1376,7,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1377,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1378,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1379,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1380,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1381,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1381,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1381,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1382,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1383,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1383,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1383,3,Cytomegalovirus enteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1383,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1383,5,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1383,6,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1383,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1383,8,Neutropenic colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1383,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1384,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1385,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1385,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1386,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1387,1,Acute motor-sensory axonal neuropathy,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
1387,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1388,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1388,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1388,3,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1388,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1388,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1388,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1388,7,Scedosporium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1388,8,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1388,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1389,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1390,1,Basal cell carcinoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1390,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1390,3,Lentigo maligna,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,Y
1390,4,Metastasis,Metastases to unknown and unspecified sites,Metastases,Neopl,N
1390,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1390,6,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1391,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1392,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1392,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1393,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1393,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
1393,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1393,4,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1393,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1393,6,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1393,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1394,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1395,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1396,1,Tonsil cancer,"Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified",Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1397,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1397,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1397,3,Vulvovaginal ulceration,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1398,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1399,1,Colectomy,Large intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1399,2,Encapsulating peritoneal sclerosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
1399,3,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
1400,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1401,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1401,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1401,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1402,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1402,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1403,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1403,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1403,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1404,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
1405,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1405,2,End stage renal disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1405,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1405,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1405,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1406,1,Pancreas transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1406,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1407,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1408,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1408,2,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
1408,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1408,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1409,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1410,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1410,2,Death,Death and sudden death,Fatal outcomes,Genrl,N
1411,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1411,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1411,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1411,4,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1411,5,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1411,6,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1411,7,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1411,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1411,9,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1411,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1412,1,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1412,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1412,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1412,4,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1413,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1413,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
1413,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1413,4,Renal and pancreas transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1414,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1414,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1415,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1416,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1416,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1417,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
1417,2,Pelvic deformity,Trunk deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
1417,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
1418,1,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1418,2,Liver transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1418,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1418,4,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1419,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1420,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1420,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1420,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1420,4,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1420,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1421,1,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1422,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
1423,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1423,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1423,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1424,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1424,2,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1424,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1425,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1425,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1426,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1426,2,Catatonia,Decreased physical activity levels,Changes in physical activity,Psych,N
1426,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1426,4,Delirium,Deliria,Deliria (incl confusion),Psych,N
1426,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1426,6,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1426,7,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1426,8,Headache,Headaches NEC,Headaches,Nerv,N
1426,9,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1426,10,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1426,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1427,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1428,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1428,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1428,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1428,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1428,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1429,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1429,2,Lymphocele,Lymphangiopathies,Lymphatic vessel disorders,Vasc,N
1429,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1429,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1430,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1431,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1431,2,Lymphocele,Lymphangiopathies,Lymphatic vessel disorders,Vasc,N
1431,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1431,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1432,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1432,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1432,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1433,1,Nikolsky's sign,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1433,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1434,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1435,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1435,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1435,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1436,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1436,2,Torsade de pointes,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1436,3,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1437,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
1437,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1437,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1437,4,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1437,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1437,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1437,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1437,8,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1438,1,Gliosis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1438,2,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1438,3,Radiation necrosis,Radiation injuries,Injuries by physical agents,Inj&P,N
1438,4,White matter lesion,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1439,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1440,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1440,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1440,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1440,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1440,5,Nocardia sepsis,Nocardia infections,Bacterial infectious disorders,Infec,N
1440,6,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1441,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1441,2,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1441,3,Enterococcal sepsis,Enterococcal infections,Bacterial infectious disorders,Infec,N
1441,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
1441,5,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
1441,6,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
1441,7,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1442,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1442,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1442,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1443,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1443,2,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1443,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1443,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1444,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1444,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1444,3,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1444,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1445,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1445,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1445,3,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1445,4,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1446,1,Alcohol interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1446,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1447,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1447,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1447,3,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
1447,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1448,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1448,2,Cytomegalovirus enteritis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1448,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1448,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1448,5,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1448,6,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1448,7,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1448,8,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
1449,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1449,2,Gastrointestinal perforation,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
1449,3,Large intestinal obstruction,Large intestinal stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
1450,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1451,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1451,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1451,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1452,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1452,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1452,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1452,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1453,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1453,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1453,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1453,4,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1454,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1454,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1454,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1454,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1455,1,Chronic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1455,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1455,3,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1455,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1455,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1456,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1456,2,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1457,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1457,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1458,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1458,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1459,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1459,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1459,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1459,4,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
1459,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1459,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1459,7,Vein disorder,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1460,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
1460,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1460,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1461,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
1461,2,Eczema infected,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1462,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1463,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1464,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1464,2,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1464,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1464,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1465,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1465,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1465,3,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1466,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1466,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1466,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1466,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1466,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1466,6,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1466,7,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
1466,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1466,9,Peripheral nerve palsy,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1466,10,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1467,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1467,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1467,3,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1467,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1468,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1468,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1468,3,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1468,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1468,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1468,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1469,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1469,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1469,3,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1470,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1470,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1470,3,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1470,4,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1471,1,Chronic allograft nephropathy,Transplant rejections,Immune disorders NEC,Immun,N
1471,2,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1472,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1472,2,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1473,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1474,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1474,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1475,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1475,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1476,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1477,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1477,2,Cardiac valve disease,Cardiac valve disorders NEC,Cardiac valve disorders,Card,N
1477,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1477,4,Left ventricular failure,Left ventricular failures,Heart failures,Card,N
1477,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1478,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1478,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1478,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1479,1,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1479,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1479,3,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1480,1,Intercepted product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1481,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1481,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1482,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1482,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1483,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1483,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1484,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1484,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1485,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1485,2,Blood lactic acid increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1485,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1485,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1485,5,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1485,6,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1486,1,Atypical pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1486,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1486,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1486,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1486,5,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1486,6,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1486,7,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1486,8,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1486,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1486,10,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1486,11,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1487,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1487,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1488,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1489,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1490,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
1490,2,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
1490,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1490,4,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1490,5,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
1490,6,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1490,7,Headache,Headaches NEC,Headaches,Nerv,N
1490,8,Optic discs blurred,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
1490,9,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1490,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1490,11,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1491,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1492,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1493,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1493,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1493,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1493,4,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1493,5,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1493,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1493,7,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1493,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1494,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1494,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1495,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1495,2,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
1495,3,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1496,1,Thrombotic thrombocytopenic purpura,Thrombocytopenias,Platelet disorders,Blood,N
1497,1,Myopathy,Myopathies,Muscle disorders,Musc,N
1498,1,Polyomavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1498,2,Trichodysplasia spinulosa,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1499,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1499,2,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1499,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1499,4,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1500,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1500,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1500,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1501,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1501,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
1502,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1503,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1503,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
1504,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1504,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1505,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1505,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1505,3,Intestine transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1505,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1505,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1505,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1506,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1506,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1506,3,Portal tract inflammation,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1506,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1506,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1507,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
1507,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1508,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1508,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1508,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1509,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1509,2,Inflammatory bowel disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1509,3,Iron deficiency anaemia,Anaemia deficiencies,Anaemias nonhaemolytic and marrow depression,Blood,N
1509,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1509,5,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1510,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1511,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1511,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1511,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1511,4,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1511,5,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1511,6,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
1511,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1511,8,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1511,9,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1511,10,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1511,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1511,12,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1511,13,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1511,14,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1511,15,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1511,16,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1511,17,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1511,18,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1511,19,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1511,20,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1511,21,Hydrocele,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
1511,22,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1511,23,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1511,24,Lymphocele,Lymphangiopathies,Lymphatic vessel disorders,Vasc,N
1511,25,Mastication disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1511,26,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1511,27,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1511,28,Muscle atrophy,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1511,29,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1511,30,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1511,31,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1511,32,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1511,33,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1511,34,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1511,35,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1511,36,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1511,37,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1511,38,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1512,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1513,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1513,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1513,3,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1513,4,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
1514,1,Behcet's syndrome,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
1514,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1514,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1514,4,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
1514,5,Gastrointestinal wall thickening,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1514,6,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1514,7,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1514,8,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1514,9,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1514,10,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1514,11,Microcytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1514,12,Mucosal hypertrophy,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1514,13,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1514,14,Pharyngeal polyp,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1514,15,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1514,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1515,1,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1515,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1515,3,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1515,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1516,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1516,2,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1516,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1517,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1517,2,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1517,3,Coarctation of the aorta,Great vessel disorders congenital,Cardiac and vascular disorders congenital,Cong,N
1517,4,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1517,5,Congenital diaphragmatic hernia,Diaphragmatic disorders congenital,Respiratory disorders congenital,Cong,N
1517,6,Congenital nail disorder,Hair and nail disorders congenital,Skin and subcutaneous tissue disorders congenital,Cong,N
1517,7,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1517,8,Dysmorphism,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
1517,9,Fryns syndrome,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
1517,10,Heart disease congenital,Cardiac disorders congenital NEC,Cardiac and vascular disorders congenital,Cong,N
1517,11,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1517,12,Microtia,External ear disorders congenital,Ear and labyrinthine disorders congenital,Cong,N
1517,13,Oesophageal atresia,Oesophageal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1517,14,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,Y
1517,15,Tracheo-oesophageal fistula,Laryngeal and tracheal disorders congenital,Respiratory disorders congenital,Cong,N
1518,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1519,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1519,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1520,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1520,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1520,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1520,4,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1521,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1521,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1521,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1522,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1523,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1523,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1524,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1524,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1524,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1524,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1525,1,Cholangitis,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
1525,2,Cryptosporidiosis infection,Cryptosporidia infections,Protozoal infectious disorders,Infec,N
1525,3,Hepatobiliary infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
1526,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1526,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1526,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1527,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1527,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1527,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1527,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1527,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1527,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1527,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1527,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1527,9,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1527,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1527,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1527,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1527,13,Vaccination site inflammation,Vaccination site reactions,Administration site reactions,Genrl,N
1528,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1529,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1530,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1530,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
1531,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1531,2,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1532,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1532,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1532,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1533,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1533,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1533,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1534,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1535,1,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1535,2,Renal tubular atrophy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1536,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1536,2,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1536,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1536,4,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1536,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1536,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1537,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1538,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1538,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1538,3,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1539,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1539,2,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
1539,3,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1539,4,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1540,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
1541,1,Lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1542,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1542,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1542,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1542,4,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1542,5,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1542,6,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1543,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1543,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1543,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1544,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1544,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
1544,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1544,4,Renal and pancreas transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1545,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1545,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1545,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1545,4,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1545,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1545,6,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1546,1,Cerebral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1546,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
1546,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1546,4,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1546,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1546,6,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1546,7,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1546,8,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1546,9,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1546,10,Hyperreflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
1546,11,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1546,12,Intracardiac mass,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1546,13,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
1546,14,Noninfective encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
1546,15,Oral fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1546,16,Performance status decreased,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1546,17,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1546,18,Pulmonary cavitation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1546,19,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1546,20,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1547,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1547,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1548,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1549,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1549,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1549,3,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1550,1,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1550,2,Pyelonephritis acute,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1551,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1552,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1553,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1553,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1554,1,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1554,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1555,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1556,1,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1556,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1557,1,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1558,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1558,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1558,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1558,4,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1558,5,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
1558,6,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1558,7,Gastrointestinal sounds abnormal,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
1558,8,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1558,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1558,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1558,11,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1559,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1560,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1560,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1561,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1562,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
1563,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1563,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1563,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1563,4,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1563,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
1564,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1564,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1564,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1565,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1566,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1567,1,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1567,2,Migraine,Migraine headaches,Headaches,Nerv,N
1568,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1569,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
1569,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1569,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1569,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1569,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1570,1,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1571,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1572,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1572,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1572,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1573,1,Herpes simplex hepatitis,Herpes viral infections,Viral infectious disorders,Infec,N
1573,2,Herpes simplex reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
1574,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1575,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1575,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1575,3,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1575,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1575,5,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1576,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1577,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1578,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1579,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1579,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1580,1,Chronic allograft nephropathy,Transplant rejections,Immune disorders NEC,Immun,N
1580,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1580,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1581,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1581,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1581,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1581,4,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1581,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1581,6,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1582,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1582,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1582,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1582,4,Babesiosis,Babesia infections,Protozoal infectious disorders,Infec,N
1582,5,Blood chloride decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1582,6,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1582,7,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1582,8,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1582,9,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1582,10,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1582,11,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1582,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1582,13,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1582,14,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1582,15,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
1582,16,Haptoglobin decreased,Haem metabolism analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1582,17,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1582,18,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1582,19,Mucosal dryness,Mucosal findings abnormal,General system disorders NEC,Genrl,N
1582,20,Myalgia,Muscle pains,Muscle disorders,Musc,N
1582,21,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1582,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1582,23,Pyuria,Infections NEC,Infections - pathogen unspecified,Infec,N
1582,24,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1582,25,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1582,26,Skin turgor decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1583,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1583,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
1584,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1584,2,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
1584,3,Polyhydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
1584,4,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1585,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1585,2,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
1586,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
1586,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1586,3,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1586,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1586,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1587,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1588,1,Arteriovenous fistula aneurysm,Cardiac and vascular procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1588,2,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
1588,3,Plasmacytoma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1588,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1588,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1588,6,Superior vena cava occlusion,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1589,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1590,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1590,2,Genitourinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1590,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1591,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1592,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1593,1,Osteonecrosis of jaw,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
1594,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1594,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1595,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1596,1,Agoraphobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1596,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1596,3,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1596,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1596,5,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1596,6,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1596,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1596,8,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1596,9,Disturbance in social behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1596,10,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1596,11,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1596,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1596,13,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1596,14,Grip strength decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1596,15,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1596,16,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1596,17,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1596,18,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1596,19,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1596,20,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
1596,21,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1596,22,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1596,23,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1596,24,Patient isolation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1596,25,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1596,26,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1596,27,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
1596,28,Psoriatic arthropathy,Psoriatic arthropathies,Joint disorders,Musc,N
1596,29,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1596,30,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1596,31,Scratch,Skin injuries NEC,Injuries NEC,Inj&P,N
1596,32,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1596,33,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1596,34,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1596,35,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1596,36,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1596,37,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
1597,1,Papillary renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
1597,2,Tumour invasion,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1598,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1599,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1599,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1599,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1599,4,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1600,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1600,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1601,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1602,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1602,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1603,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1604,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
1604,2,Chloroma,Leukaemias myeloid NEC,Leukaemias,Neopl,N
1605,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1605,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1606,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1607,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1607,2,Pouchitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1608,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1609,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1610,1,Dyschezia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
1610,2,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1611,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1612,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1613,1,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
1614,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
1614,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1614,3,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1614,4,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1614,5,Myopathy,Myopathies,Muscle disorders,Musc,N
1614,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1614,7,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1615,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1615,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1615,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1615,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1616,1,Administration site nerve damage,Administration site reactions NEC,Administration site reactions,Genrl,N
1616,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1616,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1616,4,Vaginal mucosal blistering,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1617,1,Sweat gland tumour,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
1618,1,Chloroma,Leukaemias myeloid NEC,Leukaemias,Neopl,N
1619,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
1619,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1619,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
1619,4,Staphylococcal sepsis,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1620,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1621,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
1622,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1622,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1622,3,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1622,4,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1622,5,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1622,6,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
1622,7,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1623,1,Biopsy,Histopathology procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1624,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1624,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1624,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1624,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1625,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1625,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1626,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1627,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1627,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1628,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1629,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1629,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1629,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1629,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1629,5,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1629,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1629,7,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1629,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1629,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1629,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1629,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1629,12,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1629,13,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1629,14,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1630,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1630,2,Cutaneous malacoplakia,Granulomatous and deep cutaneous inflammatory conditions,Epidermal and dermal conditions,Skin,N
1630,3,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1630,4,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1631,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1632,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1632,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1632,3,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1632,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1633,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1634,1,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
1634,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1634,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1634,4,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1634,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1634,6,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1634,7,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1634,8,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1635,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1635,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1635,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1635,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1636,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1636,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1637,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1638,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1638,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1639,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1640,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1640,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
1641,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1641,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1642,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1643,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1644,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1644,2,Nephritis,Nephritis NEC,Nephropathies,Renal,N
1645,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1645,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1645,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1645,4,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1646,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1646,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1646,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1646,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1646,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1646,6,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
1646,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1647,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1648,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1649,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1649,2,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1649,3,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1649,4,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
1649,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1649,6,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1649,7,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1650,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1651,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1652,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1653,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1654,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1654,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1655,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1655,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1656,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1656,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1656,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1656,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1656,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1656,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1656,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1656,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1656,9,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1657,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1657,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1657,3,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1658,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1658,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1658,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1659,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1659,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1659,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1659,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1659,5,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1660,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1660,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1660,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1661,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1661,2,Gingival swelling,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
1662,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1662,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1663,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1664,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1665,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1665,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1665,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1665,4,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
1665,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1665,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1665,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1665,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1665,9,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1666,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1666,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1666,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1666,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1666,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1666,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
1666,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1666,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1666,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1666,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1666,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1666,12,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1666,13,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1666,14,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1667,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1667,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1668,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1668,2,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1668,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1669,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1669,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1669,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1670,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1671,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1672,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1672,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1673,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
1673,2,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
1673,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
1674,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1675,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1675,2,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1676,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1677,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1678,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1678,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1679,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1680,1,Full blood count decreased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
1680,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1681,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1682,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1682,2,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1683,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1683,2,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1684,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1685,1,Angiomyolipoma,Soft tissue neoplasms benign NEC,Soft tissue neoplasms benign,Neopl,N
1685,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1686,1,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1686,2,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1687,1,B-lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1687,2,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1687,3,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1687,4,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
1688,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
1689,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1689,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1690,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1690,2,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1690,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1690,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1691,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1691,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1691,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1692,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1693,1,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1693,2,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
1694,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1694,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1695,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1696,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1697,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1698,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1698,2,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1698,3,Gastrointestinal oedema,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1698,4,Intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1698,5,Mesenteric haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1698,6,Pleural adhesion,Pleural conditions NEC,Pleural disorders,Resp,N
1698,7,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
1698,8,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1698,9,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1698,10,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,N
1699,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1699,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1699,3,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1699,4,Enterobacter infection,Enterobacter infections,Bacterial infectious disorders,Infec,N
1699,5,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1699,6,Intestinal dilatation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1699,7,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1699,8,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1699,9,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1699,10,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1699,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1699,12,Strongyloidiasis,Nematode infections,Helminthic disorders,Infec,Y
1700,1,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1700,2,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1701,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1702,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1702,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1703,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1703,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1704,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1705,1,Coronavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1705,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1705,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1706,1,Coronavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1706,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1706,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1707,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
1707,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1707,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1708,1,Coronavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1708,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1708,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1709,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1709,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1709,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1709,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1709,5,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1710,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1710,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1710,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
1710,4,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1710,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1710,6,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1711,1,Coronavirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1711,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1711,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1712,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1712,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1712,3,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1713,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1713,2,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1713,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1713,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1713,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1714,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1715,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1716,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1717,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1718,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1718,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1718,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1719,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1719,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1719,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1719,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1720,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1720,2,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1720,3,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1720,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1720,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1721,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1721,2,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1721,3,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1721,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1721,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1722,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1722,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1722,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1722,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1722,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1722,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1722,7,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1722,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1722,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1722,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1722,11,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1722,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1722,13,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
1722,14,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1722,15,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1722,16,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1722,17,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1722,18,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1722,19,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1723,1,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1724,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1725,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1725,2,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1726,1,Pneumonia influenzal,Influenza viral infections,Viral infectious disorders,Infec,N
1726,2,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
1727,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1727,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1727,3,Hepatitis infectious mononucleosis,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1728,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1728,2,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1728,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1728,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1728,5,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
1728,6,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1728,7,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1728,8,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1728,9,Morphoea,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1728,10,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1728,11,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1728,12,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1728,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1728,14,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1728,15,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1728,16,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1729,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1729,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1729,3,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1729,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1729,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1729,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1729,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1729,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1729,9,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1730,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1730,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1730,3,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1730,4,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1730,5,Microvillous inclusion disease,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1730,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1731,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1731,2,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1731,3,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
1731,4,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1732,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1732,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1733,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1734,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1734,2,Anticoagulant-related nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1734,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1734,4,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1735,1,Blast crisis in myelogenous leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
1735,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1735,3,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
1735,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1735,5,Ejection fraction,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1735,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1735,7,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
1735,8,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1735,9,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
1735,10,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1735,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1735,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1735,13,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1736,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1736,2,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1737,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1737,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1737,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1737,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1737,5,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1738,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1738,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1738,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1739,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1739,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1740,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1740,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1740,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1740,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1741,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1741,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1741,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1742,1,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1742,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1742,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1742,4,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1742,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1743,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1743,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1743,3,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1743,4,Hypophagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1743,5,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1743,6,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1744,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1744,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1744,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1744,4,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1744,5,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1744,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1744,7,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1745,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1745,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1745,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1746,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1747,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1747,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1748,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1749,1,Essential hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1750,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1751,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1752,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1753,1,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1753,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
1754,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1754,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1755,1,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1756,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1756,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1756,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1757,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1757,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1757,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1757,4,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1758,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1759,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1759,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1759,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1759,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1759,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1760,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1760,2,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1761,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1761,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1761,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1761,4,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1761,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1762,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1762,2,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1762,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1762,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1762,5,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1762,6,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1762,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1763,1,Autoimmune pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1763,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1763,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1763,4,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1764,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1764,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1764,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1764,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1764,5,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1765,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
1765,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
1765,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
1765,4,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
1765,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1765,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1765,7,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1765,8,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1765,9,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1765,10,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1765,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1765,12,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1765,13,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1765,14,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1765,15,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
1765,16,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1765,17,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1765,18,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1765,19,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1765,20,Multimorbidity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1765,21,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1765,22,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1765,23,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
1765,24,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1765,25,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1765,26,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1765,27,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1765,28,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1765,29,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1765,30,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1765,31,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1765,32,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1765,33,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1765,34,Soft tissue mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1765,35,Superinfection,Infections NEC,Infections - pathogen unspecified,Infec,N
1765,36,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1765,37,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1765,38,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1766,1,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1767,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1767,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1768,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1769,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1769,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1769,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1770,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1771,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1772,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1773,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1774,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1774,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1774,3,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
1775,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1775,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1776,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1776,2,Blood creatinine decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1776,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1776,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1776,5,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
1776,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1776,7,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,Y
1776,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1776,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1777,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1778,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1779,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1780,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1780,2,Renal tubular injury,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1781,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1782,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1783,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1784,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1784,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1784,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1784,4,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
1785,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1786,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1786,2,Heart transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1786,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1786,4,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
1787,1,Application site acne,Application site reactions,Administration site reactions,Genrl,N
1788,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1788,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1789,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
1789,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1789,3,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
1789,4,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1789,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1790,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1790,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1790,3,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
1790,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1790,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1790,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1790,7,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1790,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1790,9,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1790,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1790,11,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1790,12,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1790,13,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1790,14,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1790,15,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1790,16,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1790,17,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1790,18,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1790,19,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1791,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1792,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1793,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1793,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1793,3,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1793,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1793,5,Skin injury,Skin injuries NEC,Injuries NEC,Inj&P,N
1793,6,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1793,7,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1793,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1794,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1794,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1794,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
1794,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1795,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1795,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1796,1,Headache,Headaches NEC,Headaches,Nerv,N
1797,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1797,2,Nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1797,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1798,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1798,2,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
1799,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1799,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1799,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1799,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1800,1,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1801,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1802,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1802,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1802,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1802,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1803,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1804,1,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1805,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1805,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1806,1,Adenovirus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1806,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1806,3,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1806,4,Epstein-Barr virus test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
1806,5,Lung opacity,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1806,6,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1806,7,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
1806,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1806,9,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1807,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1807,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1807,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1807,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1808,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1809,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1810,1,Renal injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1810,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1811,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1812,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1812,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1812,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1813,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1813,2,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
1813,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1814,1,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1815,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1815,2,Labelled drug-drug interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1816,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1816,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1817,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1817,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1817,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1818,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1818,2,Anticoagulant-related nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1818,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1818,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1818,5,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1818,6,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1818,7,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1819,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1819,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1820,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,Y
1821,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1822,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1823,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1824,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1824,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1824,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1824,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1825,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
1825,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1826,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1827,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1828,1,Application site inflammation,Application site reactions,Administration site reactions,Genrl,N
1828,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
1828,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1828,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1828,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1828,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1829,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
1830,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1831,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1831,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1832,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1832,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1832,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1832,4,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1832,5,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1833,1,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
1834,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1835,1,Trichodysplasia spinulosa,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
1836,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1837,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1838,1,Aphthous ulcer,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1838,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1838,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1838,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1838,5,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1838,6,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
1838,7,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
1838,8,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1838,9,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1838,10,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1839,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1840,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1840,2,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1841,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1841,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1842,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1842,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1842,3,Kaposi sarcoma inflammatory cytokine syndrome,Herpes viral infections,Viral infectious disorders,Infec,N
1842,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1843,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
1843,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1844,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1844,2,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1845,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
1846,1,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1847,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1847,2,Haematoma infection,Vascular infections,Infections - pathogen unspecified,Infec,N
1847,3,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1848,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1848,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1848,3,Cytomegalovirus mucocutaneous ulcer,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1848,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1848,5,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1848,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1849,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1849,2,Hyperkeratosis,Hyperkeratoses,Cornification and dystrophic skin disorders,Skin,N
1849,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1849,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1849,5,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1849,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1849,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1850,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1851,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
1851,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1851,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1852,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1852,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1852,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1852,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
1852,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1853,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1853,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1853,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1853,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1853,5,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1854,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1854,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1854,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1854,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1854,5,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1854,6,Delirium,Deliria,Deliria (incl confusion),Psych,N
1854,7,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
1854,8,Gastrointestinal stoma complication,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1854,9,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1854,10,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1854,11,Hyperferritinaemia,Iron excess,Iron and trace metal metabolism disorders,Metab,N
1854,12,Hypertriglyceridaemia,Elevated triglycerides,Lipid metabolism disorders,Metab,N
1854,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1854,14,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1854,15,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1854,16,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1854,17,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1854,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1854,19,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1854,20,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1854,21,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1854,22,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1855,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
1855,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1856,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1856,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1856,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1856,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1856,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1856,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1856,7,Delirium,Deliria,Deliria (incl confusion),Psych,N
1856,8,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
1856,9,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1856,10,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1856,11,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1856,12,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1856,13,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1856,14,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1856,15,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
1856,16,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1856,17,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1856,18,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1856,19,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1856,20,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1856,21,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1857,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1857,2,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1857,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1857,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1857,5,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
1857,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1857,7,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
1857,8,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1857,9,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1857,10,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1857,11,Trichosporon infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1858,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1858,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1858,3,Kaposi sarcoma inflammatory cytokine syndrome,Herpes viral infections,Viral infectious disorders,Infec,N
1858,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1858,5,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1858,6,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1859,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1859,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1859,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1860,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1860,2,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
1860,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1861,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1861,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1861,3,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1862,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1863,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
1864,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1864,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1864,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1865,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1866,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1867,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1867,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1867,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1867,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
1868,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1868,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1868,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1868,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
1868,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1868,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1869,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1869,2,Haematoma infection,Vascular infections,Infections - pathogen unspecified,Infec,N
1869,3,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1870,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1871,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1872,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1872,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1872,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1872,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1872,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1872,6,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1872,7,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1872,8,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1873,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1874,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1875,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
1875,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1875,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
1875,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1875,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1875,6,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1875,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1875,8,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1875,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1876,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1876,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1876,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1877,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1878,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1879,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
1879,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1880,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1880,2,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1881,1,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1882,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1883,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1883,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1884,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1885,1,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
1885,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1886,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1887,1,Acne,Acnes,Skin appendage conditions,Skin,N
1887,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1887,3,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1887,4,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1887,5,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1887,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1887,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1887,8,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1887,9,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
1887,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1887,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1887,12,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1887,13,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1887,14,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1887,15,Skin induration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1887,16,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1887,17,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1887,18,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1887,19,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1888,1,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1889,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1889,2,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1890,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1890,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1891,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1891,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1891,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1891,4,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1892,1,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1892,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1892,3,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1893,1,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1893,2,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
1894,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1894,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1895,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
1896,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1896,2,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1896,3,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1897,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
1897,2,Inferior vena cava stenosis,Site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1897,3,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1897,4,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1897,5,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1898,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1898,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
1898,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1898,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1898,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1898,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1898,7,Delirium,Deliria,Deliria (incl confusion),Psych,N
1898,8,Gastroenteritis adenovirus,Adenoviral infections,Viral infectious disorders,Infec,N
1898,9,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1898,10,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
1898,11,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
1898,12,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1898,13,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
1898,14,Ischaemia,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1898,15,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1898,16,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1898,17,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1898,18,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1898,19,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1898,20,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1898,21,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1899,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1899,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1899,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1899,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1900,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1901,1,Renal artery stenosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1902,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1902,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
1902,3,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1902,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1903,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1903,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1904,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1904,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1904,3,Enzyme abnormality,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
1904,4,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1904,5,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1904,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1904,7,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1904,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1904,9,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1904,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1904,11,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1904,12,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1904,13,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1904,14,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1904,15,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1904,16,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1904,17,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1904,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
1905,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
1906,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1906,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1906,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1907,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1907,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1907,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1907,4,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
1908,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1908,2,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1908,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1909,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1909,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1909,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1909,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1909,5,Obstructive nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1909,6,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1909,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1910,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1910,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1910,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1910,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1911,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1911,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1911,3,Tongue erythema,Tongue signs and symptoms,Tongue conditions,Gastr,N
1912,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1912,2,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
1912,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1913,1,Multiple organ transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1913,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1914,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1915,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1915,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1916,1,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1916,2,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1917,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1917,2,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1917,3,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
1918,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1918,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1918,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1918,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1919,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1919,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1919,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1919,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1919,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1919,6,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1919,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1919,8,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1919,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1919,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1919,11,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1919,12,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1919,13,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1919,14,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1919,15,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1919,16,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1919,17,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1919,18,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1919,19,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1919,20,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1919,21,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1919,22,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1920,1,Immunosuppressant drug level,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1920,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1921,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
1922,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1922,2,Abnormal weight gain,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1922,3,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1922,4,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1922,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1922,6,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1922,7,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1922,8,Kidney fibrosis,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1922,9,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1922,10,Migraine,Migraine headaches,Headaches,Nerv,N
1922,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1922,12,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
1922,13,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1922,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1923,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1924,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1924,2,Immunosuppressant drug level,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1925,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1925,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1925,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1925,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1926,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1926,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1926,3,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1926,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1926,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1926,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1926,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1926,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
1926,9,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1927,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1928,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1929,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1929,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1929,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1930,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1930,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1931,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1931,2,Neurodermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1931,3,Prostate cancer,Prostatic neoplasms malignant,Reproductive neoplasms male malignant and unspecified,Neopl,N
1931,4,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
1932,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1933,1,Craniocerebral injury,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1933,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1933,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1933,4,Dysplasia,Trophic disorders,Tissue disorders NEC,Genrl,N
1933,5,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1933,6,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1933,7,Gingivitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
1933,8,Morphoea,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
1933,9,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
1933,10,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1933,11,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
1933,12,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1933,13,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1933,14,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1933,15,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1934,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1935,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1935,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1935,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1935,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1936,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
1937,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1937,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1938,1,Bedridden,Disability issues,Lifestyle issues,SocCi,N
1938,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1938,3,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
1938,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1938,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1939,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
1939,2,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1939,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1939,4,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
1939,5,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1939,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1939,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1939,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1940,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1940,2,Brain stem syndrome,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1940,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1940,4,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1940,5,JC virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
1940,6,Locked-in syndrome,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1940,7,Noninfective encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
1940,8,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
1940,9,Quadriparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
1941,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1941,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1941,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1941,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1942,1,Angiosarcoma,Cardiovascular neoplasms malignant and unspecified,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1942,2,Epstein-Barr virus associated lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1942,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1943,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1943,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1943,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1943,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1944,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1944,2,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1944,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1944,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1944,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
1945,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1945,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1945,3,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
1945,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1946,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1946,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1946,3,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
1947,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1947,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1947,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1947,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1948,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1948,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1948,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
1948,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1948,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
1949,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1949,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1949,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1949,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1950,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
1950,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
1950,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1950,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
1951,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1951,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1951,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1951,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1951,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1951,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1951,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1952,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1952,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1952,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1952,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1952,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1952,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1952,7,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1952,8,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
1952,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1952,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1952,11,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1953,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1954,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1955,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
1955,2,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
1956,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1957,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1957,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1957,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
1957,4,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
1957,5,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1958,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1959,1,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
1960,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
1961,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1962,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1963,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1963,2,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1963,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1963,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1963,5,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
1963,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1963,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1964,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
1965,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1966,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
1967,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
1967,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1967,3,Intestinal pseudo-obstruction,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
1967,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1967,5,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1968,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1968,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1968,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1969,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
1969,2,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
1969,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
1970,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
1971,1,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1971,2,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1971,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1971,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1971,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1971,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1972,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
1973,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1974,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1974,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1975,1,Bradycardia foetal,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1975,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1975,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1976,1,Eyelid irritation,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
1976,2,Eyelid pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1977,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1977,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1977,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1977,4,Resuscitation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1978,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
1978,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1979,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1979,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1980,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
1981,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1982,1,Adnexa uteri cyst,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1982,2,Leiomyosarcoma,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
1983,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
1983,2,Housebound,Disability issues,Lifestyle issues,SocCi,N
1983,3,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1984,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1985,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1985,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1985,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1985,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1986,1,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
1987,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1988,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1988,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1989,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1989,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
1989,3,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
1989,4,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1989,5,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1989,6,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
1989,7,Myocarditis infectious,Cardiac infections,Infections - pathogen unspecified,Infec,N
1989,8,Nodal arrhythmia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1989,9,Renal abscess,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1989,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1989,11,Thyroid gland abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1990,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
1990,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
1990,3,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
1990,4,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1990,5,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
1990,6,Myocarditis infectious,Cardiac infections,Infections - pathogen unspecified,Infec,N
1990,7,Pericarditis infective,Cardiac infections,Infections - pathogen unspecified,Infec,N
1990,8,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
1990,9,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1990,10,Splenic infarction,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1991,1,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
1992,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1992,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1992,3,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1992,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1993,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1993,2,Disseminated trichosporonosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
1993,3,Endophthalmitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
1993,4,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
1993,5,Metastases to meninges,Metastases to specified sites,Metastases,Neopl,N
1993,6,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1993,7,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1994,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1994,2,Steroid withdrawal syndrome,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1995,1,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
1995,2,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
1995,3,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1996,1,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1996,2,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
1996,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1996,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1996,5,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1996,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1996,7,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1996,8,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1996,9,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
1996,10,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1996,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1997,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
1998,1,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1999,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1999,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1999,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1999,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1999,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1999,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
1999,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2000,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2001,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2002,1,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2002,2,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2002,3,Carditis,Cardiac infections and inflammations NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2002,4,Disseminated aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
2002,5,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2002,6,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2002,7,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
2002,8,Myocardiac abscess,Cardiac infections,Infections - pathogen unspecified,Infec,N
2002,9,Nodal arrhythmia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
2002,10,Renal abscess,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2002,11,Thyroid gland abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2003,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
2003,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2003,3,Carditis,Cardiac infections and inflammations NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2003,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
2003,5,Disseminated aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2003,6,Lung abscess,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2003,7,Myocardiac abscess,Cardiac infections,Infections - pathogen unspecified,Infec,N
2003,8,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2003,9,Septic embolus,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2003,10,Splenic infarction,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2004,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2005,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2005,2,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2006,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2007,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
2008,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2009,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2009,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2009,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2010,1,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2010,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2011,1,Opportunistic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2012,1,Disseminated aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2012,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2012,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2013,1,Disseminated aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
2013,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2013,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2014,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2014,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2014,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2014,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2014,5,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2014,6,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2014,7,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2015,1,Eyelids pruritus,Ocular disorders NEC,Eye disorders NEC,Eye,N
2015,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2016,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2017,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2018,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2018,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2018,3,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
2018,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
2019,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
2020,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2020,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2021,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2021,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2021,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2022,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2023,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2023,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2023,3,Focal segmental glomerulosclerosis,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2023,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2023,5,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2024,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2024,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2024,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2025,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2026,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2026,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2026,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2026,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2027,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2028,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2028,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2028,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2029,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2029,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2029,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2029,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2030,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2030,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2030,3,Folate deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
2030,4,Hyperparathyroidism,Hyperparathyroid disorders,Parathyroid gland disorders,Endo,N
2031,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2031,2,Autoimmune neutropenia,Neutropenias,White blood cell disorders,Blood,N
2031,3,Warm autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2032,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2032,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2032,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2033,1,Gingival hypertrophy,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
2034,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2034,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2035,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2036,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2037,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2037,2,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2037,3,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2038,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2039,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2039,2,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2039,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2039,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2039,5,Lymphadenitis,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2039,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2039,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2039,8,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2039,9,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2040,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2041,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2042,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2042,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2043,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2043,2,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2043,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2043,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2044,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2045,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2046,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2047,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2047,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2047,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2048,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2048,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2049,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2049,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2050,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2050,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2051,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2051,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2052,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2052,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2052,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2052,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2053,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2054,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2054,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2054,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2055,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2055,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2055,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2056,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2056,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2056,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2057,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2057,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2057,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2058,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2058,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2058,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2059,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2059,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2059,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2060,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2060,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2060,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2061,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2061,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2061,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2062,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2062,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2062,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2063,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2063,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2064,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2064,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2065,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2065,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2065,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
2065,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2066,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2066,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2067,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2067,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2068,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2068,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2069,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2070,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2071,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2072,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
2073,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2074,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2074,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
2075,1,Back disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2076,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2076,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2076,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2076,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2076,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2076,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2076,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2076,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2076,9,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2076,10,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2076,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2076,12,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
2076,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2076,14,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2076,15,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2077,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2077,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
2077,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,Y
2077,4,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
2077,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2077,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2077,7,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2077,8,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2077,9,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2077,10,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2077,11,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2077,12,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
2077,13,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2077,14,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2077,15,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2077,16,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2077,17,Multimorbidity,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2077,18,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2077,19,Oesophageal carcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2077,20,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2077,21,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2077,22,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2077,23,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2077,24,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2077,25,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2077,26,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
2077,27,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2077,28,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2077,29,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2077,30,Soft tissue mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2077,31,Superinfection,Infections NEC,Infections - pathogen unspecified,Infec,N
2077,32,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2077,33,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2077,34,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2078,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2079,1,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2080,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2080,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2080,3,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
2081,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2081,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2081,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2081,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2081,5,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,Y
2081,6,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2081,7,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2081,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2081,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2081,10,Myalgia,Muscle pains,Muscle disorders,Musc,N
2081,11,Neck mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2081,12,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2081,13,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2081,14,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2081,15,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2081,16,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2081,17,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2082,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2083,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2083,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2083,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2084,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2084,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2085,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2085,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2085,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2085,4,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2085,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2085,6,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2085,7,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2085,8,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
2085,9,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2085,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2086,1,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,Y
2086,2,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2087,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2087,2,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
2087,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2087,4,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2088,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
2088,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2088,3,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2089,1,Hypertensive encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
2090,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2091,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2092,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
2093,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2093,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2094,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2094,2,Aversion,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2094,3,Aversion,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2094,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2094,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2094,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2094,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2094,8,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2094,9,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2094,10,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2094,11,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2094,12,Temperature regulation disorder,Body temperature altered,Body temperature conditions,Genrl,N
2094,13,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2095,1,Intestinal perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2096,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2096,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2097,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2097,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2098,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2098,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2099,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2100,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2100,2,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
2100,3,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2100,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2100,5,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2100,6,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2100,7,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2100,8,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2100,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2100,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2100,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2100,12,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
2100,13,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2100,14,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2101,1,Mechanical urticaria,Urticarias,Angioedema and urticaria,Skin,N
2101,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2102,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2103,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2104,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2104,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2104,3,Product dispensing issue,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2105,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
2105,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2106,1,Excessive cerumen production,External ear disorders NEC,External ear disorders (excl congenital),Ear,N
2106,2,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
2107,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2108,1,Bacterial endophthalmitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2108,2,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2108,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2109,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2110,1,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2110,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2110,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2111,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2112,1,Immune system disorder,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2113,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
2113,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2113,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2113,4,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2114,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2114,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2114,3,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2114,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2114,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2114,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2114,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2114,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2114,9,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
2115,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2115,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2115,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2115,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2115,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2116,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2116,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2116,3,Graft loss,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2116,4,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
2117,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2117,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
2117,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2117,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2117,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2118,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2119,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
2120,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2120,2,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2121,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2122,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2122,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2122,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2122,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2122,5,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2123,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2123,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2123,3,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2123,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2124,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
2124,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2124,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2125,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2126,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2126,2,Vitamin D deficiency,Fat soluble vitamin deficiencies and disorders,Vitamin related disorders,Metab,N
2127,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2127,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2127,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2127,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2127,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2127,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2127,7,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2128,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2129,1,Application site erythema,Application site reactions,Administration site reactions,Genrl,N
2129,2,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2129,3,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
2130,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2130,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2130,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2131,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2132,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2132,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2132,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2133,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
2133,2,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
2134,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2134,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2134,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2134,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2134,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2134,6,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2134,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2135,1,Epididymitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
2135,2,Epididymitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
2135,3,Epididymitis,Male reproductive tract infections,Infections - pathogen unspecified,Infec,N
2135,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2135,5,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2135,6,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2135,7,Osteomyelitis acute,Bone and joint infections,Infections - pathogen unspecified,Infec,N
2135,8,Paronychia,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2135,9,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
2136,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2136,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2136,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2136,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2137,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2137,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2138,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2138,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2138,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2138,4,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2138,5,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2138,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2139,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2139,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2139,3,Intervertebral discitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
2139,4,Nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2140,1,Adenocarcinoma of colon,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2141,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2141,2,Escherichia infection,Escherichia infections,Bacterial infectious disorders,Infec,N
2142,1,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2142,2,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2143,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2144,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2144,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2144,3,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2144,4,Superinfection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2145,1,Disseminated tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2146,1,Enterobacter bacteraemia,Enterobacter infections,Bacterial infectious disorders,Infec,N
2146,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2147,1,Abscess bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2147,2,Cutaneous nocardiosis,Nocardia infections,Bacterial infectious disorders,Infec,N
2147,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2148,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2148,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2148,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2148,4,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
2149,1,Metastatic squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2149,2,Squamous cell carcinoma of skin,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2150,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,Y
2150,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2151,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2151,2,Melanoma recurrent,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2151,3,Metastatic malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2152,1,Oesophageal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
2153,1,Cerebral toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2153,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2153,3,Immunosuppressant drug level,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2153,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2154,1,Oesophageal adenocarcinoma,Oesophageal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2155,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2156,1,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2156,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2157,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2157,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2157,3,Urinary tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2158,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2158,2,Cardiac infection,Cardiac infections,Infections - pathogen unspecified,Infec,N
2158,3,Central nervous system fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2158,4,Disseminated aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
2158,5,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2159,1,Brain neoplasm malignant,Central nervous system neoplasms malignant NEC,Nervous system neoplasms malignant and unspecified NEC,Neopl,N
2159,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2159,3,X-linked lymphoproliferative syndrome,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
2160,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2161,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2161,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2162,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2163,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2163,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2163,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2164,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
2165,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2165,2,Cardiac infection,Cardiac infections,Infections - pathogen unspecified,Infec,Y
2165,3,Central nervous system fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2165,4,Disseminated aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
2165,5,Infectious thyroiditis,Infections NEC,Infections - pathogen unspecified,Infec,N
2165,6,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2166,1,Fallopian tube cancer,Fallopian tube neoplasms malignant,Reproductive neoplasms female malignant and unspecified,Neopl,N
2166,2,Leiomyosarcoma,Leiomyosarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2166,3,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
2167,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
2167,2,Large intestine perforation,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
2168,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2169,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2170,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2170,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2171,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
2172,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2172,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2172,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2172,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2172,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2172,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2172,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2172,8,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2172,9,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2172,10,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2172,11,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2172,12,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2173,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2174,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
2174,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2174,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2175,1,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2175,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2176,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2176,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2177,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2178,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2178,2,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
2179,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2179,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2180,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2181,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2182,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2183,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2183,2,Pouchitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
2184,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2185,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2186,1,Retinitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2186,2,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2186,3,Visual field defect,Visual field disorders,Vision disorders,Eye,N
2187,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2188,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2188,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2188,3,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
2189,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2190,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2190,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2191,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2192,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2193,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2193,2,Renal disorder in pregnancy,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2194,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2194,2,Glomerulonephritis membranous,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
2194,3,Phospholipase A2 activity increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
2195,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2196,1,Forced expiratory volume decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
2197,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2197,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
2198,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2199,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2199,2,Disseminated varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
2199,3,Fungaemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2199,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2199,5,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
2199,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2200,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2200,2,Eyelid margin crusting,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2200,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2200,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2200,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2200,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2200,7,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
2200,8,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2200,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2201,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2201,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2202,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
2202,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2202,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2202,4,Myopathy,Myopathies,Muscle disorders,Musc,N
2202,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2203,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2204,1,Dermatitis atopic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2205,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2206,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2207,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2208,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2208,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2209,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2210,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2211,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2211,2,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2212,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2213,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2214,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2214,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2215,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2216,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2217,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2218,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2218,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2219,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2220,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
2220,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2221,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2221,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2221,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2221,4,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2221,5,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2221,6,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2221,7,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
2222,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2222,2,Haemorrhoidal haemorrhage,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
2223,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2224,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2224,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2225,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2226,1,Skin papilloma,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
2227,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2228,1,Vascular dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2229,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2230,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2231,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2231,2,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
2231,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2231,4,Occupational exposure to product,Occupational exposures,"Exposures, chemical injuries and poisoning",Inj&P,N
2231,5,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2232,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2233,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2233,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2234,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2234,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2235,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2235,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2236,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2236,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2237,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2237,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2238,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2238,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2239,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2239,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2240,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2240,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2241,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2241,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2242,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2242,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2242,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2242,4,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2242,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2242,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2242,7,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2242,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2243,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2244,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2244,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
2245,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2245,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2245,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2245,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2246,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2246,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2247,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2248,1,Acne,Acnes,Skin appendage conditions,Skin,N
2248,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2248,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2249,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2250,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2250,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2250,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2251,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2251,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2251,3,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2251,4,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2251,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
2251,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2251,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2251,8,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2252,1,B-cell lymphoma,B-cell lymphomas NEC,Lymphomas non-Hodgkin's B-cell,Neopl,N
2252,2,Gastrointestinal lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,N
2252,3,Streptococcal urinary tract infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2253,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2254,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2255,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2255,2,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2256,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2256,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2257,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2258,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2258,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2259,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2259,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2260,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2260,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2261,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2262,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2262,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2263,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
2264,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2264,2,Gastrointestinal bacterial overgrowth,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2264,3,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2264,4,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2264,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2265,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2266,1,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
2266,2,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2267,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2267,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2268,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2268,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2268,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2269,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2270,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2271,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2271,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2272,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2272,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2272,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2273,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2274,1,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2275,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2275,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2275,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2276,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2277,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2277,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2278,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2278,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2279,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2279,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2280,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2280,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2281,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2281,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2282,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2282,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2283,1,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2284,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2284,2,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2284,3,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2284,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2285,1,Herpes simplex oesophagitis,Herpes viral infections,Viral infectious disorders,Infec,N
2285,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2285,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2285,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2286,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2287,1,Immune-mediated hepatic disorder,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2287,2,Immunosuppressant drug level abnormal,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2288,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2289,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2289,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2289,3,Immunosuppressant drug level abnormal,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2290,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2290,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2290,3,Immunosuppressant drug level abnormal,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2290,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
2291,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2291,2,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2292,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2293,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2294,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2295,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2296,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2297,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2298,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2298,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2298,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2299,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2300,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2301,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2302,1,Peritoneal dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
2303,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2304,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2305,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2306,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2307,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2308,1,Hepatitis E,Hepatitis virus infections,Viral infectious disorders,Infec,N
2309,1,Burkholderia gladioli infection,Burkholderia infections,Bacterial infectious disorders,Infec,N
2309,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2309,3,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
2309,4,Wound infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2310,1,Blood uric acid abnormal,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
2311,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2312,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2312,2,Glucose-6-phosphate dehydrogenase deficiency,Inborn errors of carbohydrate metabolism (excl glucose),Metabolic and nutritional disorders congenital,Cong,N
2313,1,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2313,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2314,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2314,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2315,1,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2315,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2316,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2317,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2317,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2318,1,Norovirus infection,Caliciviral infections,Viral infectious disorders,Infec,N
2318,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2319,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2319,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2320,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2320,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2320,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2321,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2321,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2322,1,Cytomegalovirus chorioretinitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2322,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2322,3,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2322,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2322,5,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2322,6,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
2322,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2322,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2322,9,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2322,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2322,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2322,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2322,13,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2322,14,Retinal scar,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
2322,15,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2323,1,Headache,Headaches NEC,Headaches,Nerv,N
2323,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2323,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2323,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2323,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2324,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2325,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2325,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2325,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2326,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
2327,1,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
2328,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2329,1,Anti-erythropoietin antibody negative,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2329,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2330,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2330,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2331,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2332,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2333,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2334,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2335,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2336,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2336,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2337,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2337,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2337,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2338,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2338,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2339,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2339,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2339,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2339,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2340,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2341,1,Full blood count increased,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
2342,1,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
2343,1,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
2344,1,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
2345,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2346,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2347,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2347,2,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2347,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2348,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2349,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2350,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2350,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2351,1,Groin infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2351,2,Herpes zoster cutaneous disseminated,Herpes viral infections,Viral infectious disorders,Infec,N
2351,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2352,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2353,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2354,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2354,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
2354,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2355,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2356,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2357,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2357,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2357,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2357,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2358,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2358,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
2358,3,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2358,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2358,5,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2359,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2359,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
2360,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
2360,2,Enterococcal infection,Enterococcal infections,Bacterial infectious disorders,Infec,N
2360,3,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2360,4,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2360,5,Renal graft infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2360,6,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2361,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2362,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2362,2,Warm autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
2363,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2363,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2363,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2363,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2363,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2363,6,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2363,7,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2363,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2363,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2363,10,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2363,11,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2364,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2365,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2365,2,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2365,3,Human herpesvirus 8 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2365,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2365,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2365,6,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2365,7,Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,N
2365,8,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2365,9,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2365,10,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2365,11,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2366,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2367,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2368,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2369,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2370,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2370,2,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
2370,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2371,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2372,1,Angina unstable,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2373,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2374,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2375,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2376,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2377,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2378,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2379,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2380,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2381,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2382,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2383,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2384,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2384,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2384,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2385,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2386,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2387,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
2388,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2388,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2388,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
2388,4,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2389,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2389,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2389,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2389,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2389,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2389,6,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
2389,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2389,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2389,9,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2389,10,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
2390,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2390,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2391,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2392,1,Abscess fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
2392,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
2392,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2392,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2392,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2392,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2392,7,Iliac artery disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2392,8,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
2392,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2392,10,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2392,11,Renal artery perforation,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2392,12,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2393,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2394,1,Human polyomavirus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
2394,2,Trichodysplasia spinulosa,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
2395,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2396,1,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2397,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2397,2,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2397,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2397,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2398,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2398,2,Reversed hot-cold sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2399,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
2399,2,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
2399,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2399,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2399,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2399,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
2399,7,Iliac artery disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
2399,8,Infective aneurysm,Vascular infections,Infections - pathogen unspecified,Infec,N
2399,9,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2399,10,Pneumonia acinetobacter,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2399,11,Renal artery perforation,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2399,12,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2400,1,Coronary artery bypass,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
2401,1,Tuberculosis of genitourinary system,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2402,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2403,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
2404,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2405,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
2405,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2405,3,Lipase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
2405,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2405,5,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2406,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2407,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2408,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2408,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2409,1,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
2409,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2410,1,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2411,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2411,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2411,3,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2412,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2412,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2412,3,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
2412,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2412,5,Trichodysplasia spinulosa,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
2413,1,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2413,2,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2414,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2415,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2415,2,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2416,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2417,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2417,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2417,3,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2418,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2418,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2418,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2418,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2419,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2419,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2419,3,Headache,Headaches NEC,Headaches,Nerv,N
2419,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2419,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2419,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2419,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2420,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2420,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2421,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2422,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2422,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2423,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2423,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2423,3,Trichodysplasia spinulosa,Papulosquamous conditions,Epidermal and dermal conditions,Skin,N
2424,1,Phaeohyphomycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
2425,1,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
2425,2,Headache,Headaches NEC,Headaches,Nerv,N
2425,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2425,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
2426,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2426,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2426,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2426,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2426,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2426,6,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2426,7,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2426,8,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2426,9,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2426,10,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2426,11,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2426,12,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2427,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2428,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2429,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2429,2,Headache,Headaches NEC,Headaches,Nerv,N
2429,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2429,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2429,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2429,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2429,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2430,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2430,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2430,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2430,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2430,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2431,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2431,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
2431,3,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
2431,4,Epinephrine increased,Adrenal medulla tests,Endocrine investigations (incl sex hormones),Inv,N
2431,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2431,6,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2431,7,Madarosis,Alopecias,Skin appendage conditions,Skin,N
2431,8,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2431,9,Mental fatigue,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
2431,10,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
2431,11,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2431,12,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2431,13,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2431,14,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2431,15,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2431,16,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2431,17,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2431,18,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2431,19,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
2431,20,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2431,21,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2431,22,Skin temperature,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2431,23,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2431,24,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2431,25,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2431,26,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2432,1,Alternaria infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2432,2,Fungal skin infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
2433,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2433,2,Orofacial granulomatosis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
2433,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2434,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2435,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2435,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
2436,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2437,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2438,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2439,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2440,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2440,2,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2441,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2441,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2442,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2442,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2442,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
2442,4,Headache,Headaches NEC,Headaches,Nerv,N
2442,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2442,6,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2442,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2442,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2443,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2443,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2444,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2445,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2446,1,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
2446,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2447,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2448,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2449,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2450,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2451,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2452,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
2453,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2453,2,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2453,3,Drug specific antibody present,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2453,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2453,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2453,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2454,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2455,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2456,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2457,1,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
2458,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
2459,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2460,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2461,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
2462,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2462,2,Headache,Headaches NEC,Headaches,Nerv,N
2462,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
2462,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2462,5,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
2462,6,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2462,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2463,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2464,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2465,1,Morganella infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2465,2,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
2466,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2467,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2468,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2469,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2470,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2470,2,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2470,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2470,4,Morganella infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2470,5,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
2471,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2472,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2473,1,Graft infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2473,2,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2473,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2473,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2473,5,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2474,1,Coinfection,Infections NEC,Infections - pathogen unspecified,Infec,N
2474,2,Cytomegalovirus hepatitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2474,3,Graft infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2474,4,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2474,5,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2474,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2474,7,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2475,1,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2475,2,Graft infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2475,3,Hepatitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
2475,4,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
2475,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2475,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2475,7,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2476,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2477,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2477,2,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
2478,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2479,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2480,1,Chemotherapy,Chemotherapies,Therapeutic procedures and supportive care NEC,Surg,N
2481,1,Joint injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
2482,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2482,2,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
2483,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2484,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2485,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2486,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2487,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2488,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2489,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2490,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2490,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
2490,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
2490,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2490,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2490,6,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2490,7,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2490,8,Ear swelling,Ear disorders NEC,Aural disorders NEC,Ear,N
2490,9,Eczema herpeticum,Herpes viral infections,Viral infectious disorders,Infec,N
2490,10,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2490,11,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2490,12,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
2490,13,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2490,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2490,15,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2490,16,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
2490,17,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
2490,18,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2490,19,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2490,20,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2490,21,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
2490,22,Skin odour abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2490,23,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2490,24,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2490,25,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
2490,26,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2490,27,Weight fluctuation,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
2491,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2492,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
2492,2,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
2492,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2493,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2494,1,Deafness,Hearing losses,Hearing disorders,Ear,N
2494,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2495,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2495,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2496,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2496,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2497,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
2497,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2498,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2499,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
2500,1,Biopsy kidney,Urinary tract histopathology procedures,Renal and urinary tract investigations and urinalyses,Inv,N
2501,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2502,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
2503,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2503,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2504,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
2504,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
2504,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2504,4,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2505,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2505,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2506,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2506,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2507,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2507,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2508,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2508,2,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2509,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2509,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2510,1,Transplant,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2511,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2511,2,Type 1 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2512,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2512,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2512,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2512,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2513,1,Complications of transplanted lung,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2513,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2513,3,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2513,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2513,5,Post procedural infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2514,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2515,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2516,1,Oesophageal mass,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2517,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2518,1,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
2519,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2520,1,Lung adenocarcinoma,Non-small cell neoplasms malignant of the respiratory tract cell type specified,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
2521,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2522,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2523,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2524,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2525,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2526,1,Limb operation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2527,1,Blood test,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2528,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
2528,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2529,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2530,1,Herpes zoster reactivation,Herpes viral infections,Viral infectious disorders,Infec,N
2531,1,Varicella zoster pneumonia,Herpes viral infections,Viral infectious disorders,Infec,Y
2532,1,Walking aid user,Disability issues,Lifestyle issues,SocCi,N
2533,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2534,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2535,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2536,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2537,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2538,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2539,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2539,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2539,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2539,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2539,5,Skin hyperpigmentation,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
2540,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2540,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2541,1,Conjunctivitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
2541,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2541,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2541,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2541,5,Oral herpes,Herpes viral infections,Viral infectious disorders,Infec,N
2541,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2542,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2543,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2544,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2544,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2545,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2546,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2547,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2547,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2547,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2547,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2547,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2548,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2549,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2550,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2551,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2551,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2551,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2551,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2551,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2551,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2551,7,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2551,8,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2551,9,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2551,10,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
2551,11,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2551,12,Skin atrophy,Skin hypoplasias and atrophies,Cornification and dystrophic skin disorders,Skin,N
2551,13,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2551,14,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2551,15,Xeroderma,Ichthyoses,Cornification and dystrophic skin disorders,Skin,N
2552,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2553,1,Malignant melanoma,Skin melanomas (excl ocular),Skin neoplasms malignant and unspecified,Neopl,N
2554,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2555,1,Immunosuppressant drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2556,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2557,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2558,1,Immunosuppressant drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2559,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2560,1,Diabetic complication,Diabetic complications NEC,Diabetic complications,Metab,N
2561,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2561,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2562,1,Diabetic complication,Diabetic complications NEC,Diabetic complications,Metab,N
2563,1,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2564,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2565,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2566,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2567,1,Kidney transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
2568,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2568,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2569,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2570,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2570,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2570,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2571,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
2572,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2572,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2572,3,Immunosuppression,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2573,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2574,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2575,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2576,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2576,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2577,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
2577,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2578,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2578,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
2579,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2579,2,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
2579,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
2580,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
2580,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2581,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2581,2,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2582,1,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2583,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2584,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
2584,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2584,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2585,1,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
2585,2,Squamous cell carcinoma,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2586,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
2587,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2587,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2588,1,Bowen's disease,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2588,2,Papilloma viral infection,Papilloma viral infections,Viral infectious disorders,Infec,N
2589,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
2590,1,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
2591,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
2592,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2593,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2594,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2594,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
2594,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2594,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
2594,5,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
2594,6,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2594,7,Topical steroid withdrawal reaction,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
2595,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2595,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2596,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2597,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2597,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
2597,3,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2597,4,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2598,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2599,1,Beta haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2599,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
2599,3,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
2599,4,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2599,5,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2600,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2600,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2601,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2602,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2603,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2603,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2604,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
2605,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
2606,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2606,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2606,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2607,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2608,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2609,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2610,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2610,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2611,1,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2612,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2612,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2612,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2612,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2612,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2612,6,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2613,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2614,1,Coronary artery bypass,Arterial therapeutic procedures (excl aortic),Vascular therapeutic procedures,Surg,N
2614,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2615,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2616,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2616,2,Polyomavirus-associated nephropathy,Polyomavirus infections,Viral infectious disorders,Infec,N
2617,1,Pneumonia influenzal,Influenza viral infections,Viral infectious disorders,Infec,N
2617,2,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
2617,3,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2618,1,Alpha haemolytic streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
2618,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2618,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2618,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
2618,5,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2619,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2620,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2621,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2622,1,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2622,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2622,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2622,4,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
2622,5,Pyelonephritis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
2623,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2623,2,Device related infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2623,3,Donor specific antibody present,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
2623,4,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2623,5,Rhinovirus infection,Rhinoviral infections,Viral infectious disorders,Infec,N
2624,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2625,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,Y
2626,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2626,2,Lung transplant,Bronchial and pulmonary therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
2627,1,Skin cancer,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
2628,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
2628,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2628,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
2628,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
2628,5,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2628,6,Lupus-like syndrome,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2628,7,Lymph node tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
2628,8,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
2629,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2629,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2630,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2630,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
2631,1,Vascular hyalinosis,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2632,1,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
2632,2,Meningitis aseptic,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
2632,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2633,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
2633,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2634,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2634,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2635,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2635,2,Application site warmth,Application site reactions,Administration site reactions,Genrl,N
2635,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2635,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2635,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2635,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2635,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2635,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2635,9,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
2635,10,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
2635,11,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2636,1,Vascular hyalinosis,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
2637,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2637,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2637,3,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2637,4,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2637,5,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2637,6,Iridocyclitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
2637,7,Polyomavirus viraemia,Polyomavirus infections,Viral infectious disorders,Infec,N
2637,8,Viral uveitis,Viral infections NEC,Viral infectious disorders,Infec,N
2638,1,Headache,Headaches NEC,Headaches,Nerv,N
2639,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2639,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2639,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2639,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2640,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2640,2,Pulmonary sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
2641,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2641,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2642,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2642,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2643,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2643,2,Feeding tube user,Dietary and nutritional issues,Lifestyle issues,SocCi,N
2644,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2645,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2646,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
2647,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
2647,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
2648,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2648,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2649,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2649,2,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2649,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2649,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2650,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2651,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2652,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2653,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2654,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2655,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2656,1,Immune tolerance induction,Prophylactic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2657,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2657,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
2658,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2659,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2660,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2661,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2662,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2662,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2662,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2663,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
2664,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2665,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2666,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2667,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2668,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2668,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2669,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2669,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2669,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2670,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2671,1,Coma,Coma states,Neurological disorders NEC,Nerv,N
2671,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
2671,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
2671,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
2672,1,Incorrect product dosage form administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
2672,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2673,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2673,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2673,3,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2674,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
2675,1,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
2676,1,Anosognosia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
2676,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2676,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2676,4,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
2676,5,Renal vessel disorder,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2676,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
2676,7,Visual pathway disorder,Neurologic visual problems NEC,Neurological disorders of the eye,Nerv,N
2677,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2678,1,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2679,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2680,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2681,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2682,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
2682,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2683,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2684,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
2684,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
2684,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2685,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2686,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2687,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2687,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2687,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
2687,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2688,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
2689,1,Central nervous system immune reconstitution inflammatory response,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
2689,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2689,3,Eye infection toxoplasmal,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2689,4,Toxoplasmosis,Toxoplasma infections,Protozoal infectious disorders,Infec,N
2690,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2691,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2692,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2693,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2694,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2695,1,Drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
2696,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2697,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2697,2,Urinary tract injury,Renal and urinary tract injuries NEC,Injuries NEC,Inj&P,N
2698,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
2698,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
2699,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2699,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2699,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2700,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2700,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2701,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2701,2,Erosive duodenitis,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2701,3,Helicobacter gastritis,Helicobacter infections,Bacterial infectious disorders,Infec,N
2701,4,Myelodysplastic syndrome with single lineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,N
2701,5,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
2702,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
2702,2,Headache,Headaches NEC,Headaches,Nerv,N
2702,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
2703,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2704,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
2705,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2706,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2706,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2707,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2707,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2707,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
2707,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
2708,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2708,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2709,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
2709,2,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2710,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
2710,2,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2710,3,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
2711,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2711,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
2712,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2712,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2713,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2714,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2714,2,Myelodysplastic syndrome with single lineage dysplasia,Myelodysplastic syndromes,Leukaemias,Neopl,N
2714,3,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
2715,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2716,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2716,2,Erosive duodenitis,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
2716,3,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
2716,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
2716,5,Parvovirus B19 infection,Parvoviral infections,Viral infectious disorders,Infec,N
2716,6,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2716,7,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
2717,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2717,2,Transplantation complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2717,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
2718,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2718,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2718,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2719,1,Anorectal discomfort,Anal and rectal signs and symptoms,Anal and rectal conditions NEC,Gastr,N
2720,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2721,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2722,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2723,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2724,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2725,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
2725,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
2726,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2726,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2727,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2728,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2728,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
2729,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
2730,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
2731,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
2732,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
2733,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
2734,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2734,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
2734,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
2734,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
2734,5,Miliaria,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
2734,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
2734,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2734,8,Self esteem decreased,Personality disorders NEC,Personality disorders and disturbances in behaviour,Psych,N
2734,9,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2734,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2734,11,Stress at work,Employment issues,Economic and housing issues,SocCi,N
2735,1,Allergic oedema,Allergic conditions NEC,Allergic conditions,Immun,N
2735,2,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
2735,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2735,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
2735,5,Rosacea,Rosaceas,Skin appendage conditions,Skin,N
2735,6,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
2736,1,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2737,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2737,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2737,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
2738,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
2739,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
2740,1,Chronic inflammatory demyelinating polyradiculoneuropathy,Chronic polyneuropathies,Peripheral neuropathies,Nerv,N
2741,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2741,2,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2741,3,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2742,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2743,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2743,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
2743,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2744,1,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
2745,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2746,1,Death,Death and sudden death,Fatal outcomes,Genrl,N
2747,1,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
2747,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2748,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
2749,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2749,2,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
2749,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2749,4,Transplantation complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2750,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
2751,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2751,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2751,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2751,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
2751,5,Pseudolymphoma,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
2752,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2752,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2752,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2752,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2753,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
2753,2,Dermatophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2753,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
2753,4,Trichophytosis,Tinea infections,Fungal infectious disorders,Infec,N
2754,1,Complications of transplanted kidney,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
2754,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
2754,3,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
2754,4,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
2755,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2756,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2756,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
2756,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2756,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2756,5,Headache,Headaches NEC,Headaches,Nerv,N
2756,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
2756,7,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
2756,8,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2757,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
2757,2,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
2757,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
2758,1,Critical illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2759,1,Foot amputation,Limb therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
2760,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2760,2,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
2760,3,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
2761,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2762,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
2763,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
2764,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
2765,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2765,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
2765,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
